<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37342500</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature.</ArticleTitle><Pagination><StartPage>1187163</StartPage><MedlinePgn>1187163</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1187163</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2023.1187163</ELocationID><Abstract><AbstractText>Some patients remain unwell for months after "recovering" from acute COVID-19. They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance and other symptoms that greatly interfere with their ability to function and that can leave some people housebound and disabled. The illness (Long COVID) is similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) as well as to persisting illnesses that can follow a wide variety of other infectious agents and following major traumatic injury. Together, these illnesses are projected to cost the U.S. trillions of dollars. In this review, we first compare the <i>symptoms</i> of ME/CFS and Long COVID, noting the considerable similarities and the few differences. We then compare in extensive detail the underlying <i>pathophysiology</i> of these two conditions, focusing on abnormalities of the central and autonomic nervous system, lungs, heart, vasculature, immune system, gut microbiome, energy metabolism and redox balance. This comparison highlights how strong the evidence is for each abnormality, in each illness, and helps to set priorities for future investigation. The review provides a current road map to the extensive literature on the underlying biology of both illnesses.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Komaroff and Lipkin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Komaroff</LastName><ForeName>Anthony L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipkin</LastName><ForeName>W Ian</ForeName><Initials>WI</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 AI138370</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome (CFS)</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis (ME)</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">post-infectious fatigue syndrome</Keyword><Keyword MajorTopicYN="N">post-intensive care unit syndrome</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>12</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37342500</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press; (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H, McCorkell L, Vogel J, Topol E. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach K. Is Long COVID Worsening the Labor Shortage?. Washington, D. C: Brookings Institution; (2022).</Citation></Reference><Reference><Citation>Cutler D, Summers L. The COVID-19 pandemic and the $16 trillion virus. JAMA. (2020) 324:1495&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604733</ArticleId><ArticleId IdType="pubmed">33044484</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler D. The costs of long COVID. JAMA Health Forum. (2022) 3:e221809.</Citation><ArticleIdList><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R, et al. Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen D, Ng R, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. (2022) 185:881&#x2013;95.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie C, Lowe D, McAuley A, Winter A, Mills N, Black C, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. (2022) 13:5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>You J, Zhang L, Ni-Jia-Ti M, Zhang J, Hu F, Chen L, et al. Abnormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J Infect. (2020) 81:e150&#x2013;2. 10.1016/j.jinf.2020.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7273134</ArticleId><ArticleId IdType="pubmed">32512021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Perl D, Nair G, Li W, Maric D, Murray H, et al. Microvascular injury in the brains of patients with Covid-19. N Engl J Med. (2021) 384:481&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S, Ramelli S, Grazioli A, Chung J, Singh M, Yinda C, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. (2022) 612:758&#x2013;63. 10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. (2021) 32:151&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term gastrointestinal outcomes of COVID-19. Nat Commun. (2023) 14:983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9992516</ArticleId><ArticleId IdType="pubmed">36882400</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. (2021) 594:259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. (2022) 10:311&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T, Weitzer D. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2014;A systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas). (2021) 57:418. 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandman C, Barron J, Nackoul K, Goldstein J, Fidler F. Memory deficits associated with chronic fatigue immune dysfunction syndrome. Biol Psychiatry. (1993) 33:618&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">8329493</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLuca J, Johnson S, Beldowicz D, Natelson B. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. J Neurol Neurosurg Psychiatry. (1995) 58:38&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1073266</ArticleId><ArticleId IdType="pubmed">7823065</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcel B, Komaroff A, Fagioli L, Kornish R, Albert M. Cognitive deficits in patients with chronic fatigue syndrome. Biol Psychiatry. (1996) 40:535&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">8879474</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLuca J, Johnson S, Ellis S, Natelson B. Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. J Neurol Neurosurg Psychiatry. (1997) 62:151&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC486726</ArticleId><ArticleId IdType="pubmed">9048715</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiersky L, Johnson S, Lange G, Natelson B, DeLuca J. Neuropsychology of chronic fatigue syndrome: a critical review. J Clin Exp Neuropsychol. (1997) 19:560&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">9342690</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly E, Komaroff A, Bloomingdale K, Wilson S, Albert M. Neuropsychological functioning in patients with chronic fatigue syndrome, multiple sclerosis and depression. App Neuropsychol. (2001) 8:12&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">11388119</ArticleId></ArticleIdList></Reference><Reference><Citation>Michiels V, Cluydts R. Neuropsychological functioning in chronic fatigue syndrome: a review. Acta Psychiatr Scand. (2001) 103:84&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">11167310</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLuca J, Christodoulou C, Diamond B, Rosenstein, Kramer N, Natelson B. Working memory deficits in chronic fatigue syndrome: differentiating between speed and accuracy of information processing. J Int Neuropsychol Soc. (2004) 10:101&#x2013;9. 10.1017/S1355617704101124</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617704101124</ArticleId><ArticleId IdType="pubmed">14751012</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson A, Toft A, O&#x2019;Carroll R. Neuropsychological functioning, illness perception, mood and quality of life in chronic fatigue syndrome, autoimmune thyroid disease and healthy participants. Psychol Med. (2009) 39:1567&#x2013;76. 10.1017/S0033291708004960</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291708004960</ArticleId><ArticleId IdType="pubmed">19144216</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockshell S, Mathias J. Cognitive functioning in chronic fatigue syndrome: a meta-analysis. Psychol Med. (2010) 40:1253&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">20047703</ArticleId></ArticleIdList></Reference><Reference><Citation>Den Eede F, Moorkens G, Hulstijn W, Maas Y, Schrijvers D, Stevens S, et al. Psychomotor function and response inhibition in chronic fatigue syndrome. Pscyhiatry Res. (2011) 186:367&#x2013;72. 10.1016/j.psychres.2010.07.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2010.07.022</ArticleId><ArticleId IdType="pubmed">20797797</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasouli O, Gotaas M, Stensdotter A, Skovlund E, Landr&#xf8; N, D&#xe5;st&#xf8;l P, et al. Neuropsychological dysfunction in chronic fatigue syndrome and the relation between objective and subjective findings. Neuropsychology. (2019) 33:658&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">31169386</ArticleId></ArticleIdList></Reference><Reference><Citation>Murga I, Aranburu L, Gargiulo P, Gomez-Esteban J, Lafuente J. The maintained attention assessment in patients affected by myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker? J Transl Med. (2021) 19:494. 10.1186/s12967-021-03153-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03153-1</ArticleId><ArticleId IdType="pmc">PMC8645147</ArticleId><ArticleId IdType="pubmed">34863209</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoun Sebaiti M, Hainselin M, Gounden Y, Sirbu C, Sekulic S, Lorusso L, et al. Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Sci Rep. (2022) 12:2157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828740</ArticleId><ArticleId IdType="pubmed">35140252</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Quiros J, Lacasa-Cazcarra M, Alegre-Martin J, Sanmartin-Sentanes R, Almirall M, Launois-Obregon P, et al. The conners continuous performance test CPT3: is it a reliable marker to predict neurocognitive dysfunction in Myalgic encephalomyelitis/chronic fatigue syndrome? Front Psychol. (2023) 14:1127193. 10.3389/fpsyg.2023.1127193</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2023.1127193</ArticleId><ArticleId IdType="pmc">PMC10008938</ArticleId><ArticleId IdType="pubmed">36923151</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D, Nagelkirk P, Peckerman A, Poluri A, Mores J, Natelson B. Exercise and cognitive performance in chronic fatigue syndrome. Med Sci Sports Exerc. (2005) 37:1460&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16177595</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmaling K, DiClementi J, Cullum C, Jones J. Cognitive functioning in chronic fatigue syndrome and depression: a preliminary comparison. Psychosom Med. (1994) 56:383&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7809336</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant E, Adam S, Gillain B, Lambert M, Masquelier E, Seron X. Cognitive deficits in patients with chronic fatigue syndrope compared to those with major depressive disorder and healthy controls. Clin Neurol Neurosurg. (2011) 113:295&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">21255911</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange G, Steffener J, Cook D, Bly B, Christodoulou C, Liu W, et al. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. NeuroImage. (2005) 26:513&#x2013;24. 10.1016/j.neuroimage.2005.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2005.02.011</ArticleId><ArticleId IdType="pubmed">15907308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D, O&#x2019;Connor P, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. NeuroImage. (2007) 36:108&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">17408973</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Z, Finegan K, Bhuta S, Ireland T, Staines D, Marshall-Gradisnik S, et al. Brain function characteristics of chronic fatigue syndrome: a task fMRI study. Neuroimage Clin. (2018) 19:279&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6051500</ArticleId><ArticleId IdType="pubmed">30035022</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D, Light A, Light K, Broderick G, Shields M, Dougherty R, et al. Neural consequences of post-exertion malaise in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun. (2017) 62:87&#x2013;99. 10.1016/j.bbi.2017.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2017.02.009</ArticleId><ArticleId IdType="pubmed">28216087</ArticleId></ArticleIdList></Reference><Reference><Citation>Santamarina-Perez P, Eiroa-Orosa F, Freniche V, Moreno-Mayos A, Alegre J, Saez N, et al. Length of illness does not predict cognitive dysfunction in chronic fatigue syndrome. Appl Neuropsychol. (2011) 18:216&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">21846221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockshell S, Mathias J. Test effort in persons with chronic fatigue syndrome when assessed using the validity indicator profile. J Clin Exp Neuropsychol. (2012) 34:679&#x2013;87. 10.1080/13803395.2012.668176</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13803395.2012.668176</ArticleId><ArticleId IdType="pubmed">22440059</ArticleId></ArticleIdList></Reference><Reference><Citation>Cope H, Pernet A, Kendall B, David A. Cognitive functioning and magnetic resonance imaging in chronic fatigue. Br J Psychiatry. (1995) 167:86&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">7551617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahurin R, Goldberg J, Claypoole K, Arguelles L, Ashton S, Buchwald D. Cognitive processing in monozygotic twins discordant for chronic fatigue syndrome. Neuropsychology. (2004) 18:232&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15099145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. (2021) 144:1263&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Chatfield D, Am M, Jolly A, Trender W, Hellyer P, et al. Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. EClinicalMedicine. (2022) 47:101417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9048584</ArticleId><ArticleId IdType="pubmed">35505938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ollila H, Pihlaja R, Koskinen S, Tuulio-Henriksson A, Salmela V, Tiainen M, et al. Long-term cognitive functioning is impaired in ICU-treated COVID-19 patients: a comprehensive controlled neuropsychological study. Crit Care. (2022) 26:223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9297673</ArticleId><ArticleId IdType="pubmed">35858899</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G, Monaghan A, Xue F, Duggan E, Romero-Ortuno R. Comprehensive clinical characterisation of brain fog in adults reporting long COVID symptoms. J Clin Med. (2022) 11:3440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9224578</ArticleId><ArticleId IdType="pubmed">35743516</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertuccelli M, Ciringione L, Rubega M, Bisiacchi P, Masiero S, Del Felice A. Cognitive impairment in people with previous COVID-19 infection: a scoping review. Cortex. (2022) 154:212&#x2013;30. 10.1016/j.cortex.2022.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.06.002</ArticleId><ArticleId IdType="pmc">PMC9187867</ArticleId><ArticleId IdType="pubmed">35780756</ArticleId></ArticleIdList></Reference><Reference><Citation>Azcue N, Gomez-Esteban J, Acera M, Tijero B, Fernandez T, Ayo-Mentxakatorre N, et al. Brain fog of post-COVID-19 condition and chronic fatigue syndrome, same medical disorder? J Transl Med. (2022) 20:569. 10.1186/s12967-022-03764-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03764-2</ArticleId><ArticleId IdType="pmc">PMC9724286</ArticleId><ArticleId IdType="pubmed">36474290</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti G, Agosta F, Canu E, Basaia S, Barbieri A, Cardamone R, et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol. (2022) 269:3400&#x2013;12. 10.1007/s00415-022-11047-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11047-5</ArticleId><ArticleId IdType="pmc">PMC8898558</ArticleId><ArticleId IdType="pubmed">35249144</ArticleId></ArticleIdList></Reference><Reference><Citation>Andriuta D, Si-Ahmed C, Roussel M, Constans J, Makki M, Aarabi A, et al. Clinical and imaging determinants of neurocognitive disorders in post-acute COVID-19 patients with cognitive complaints. J Alzheimers Dis. (2022) 87:1239&#x2013;50. 10.3233/JAD-215506</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-215506</ArticleId><ArticleId IdType="pubmed">35431242</ArticleId></ArticleIdList></Reference><Reference><Citation>Samudyata, Oliveira AO, Malwade S, Rufino de Sousa N, Goparaju SK, Gracias J, et al. SARS-CoV-2 promotes microglial synapse elimination in human brain organoids. Mol Psychiatry. (2022) 27:3939&#x2013;50. 10.1038/s41380-022-01786-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01786-2</ArticleId><ArticleId IdType="pmc">PMC9533278</ArticleId><ArticleId IdType="pubmed">36198765</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz R, Komaroff A, Garada B, Gleit M, Doolittle T, Bates D, et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. AJR Am J Roentgenol. (1994) 162:943&#x2013;51. 10.2214/ajr.162.4.8141022</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/ajr.162.4.8141022</ArticleId><ArticleId IdType="pubmed">8141022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka H, Matsushima R, Tamai H, Kajimoto Y. Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance. J Pediatr. (2002) 140:412&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12006954</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmaling K, Lewis D, Fiedelak J, Mahurin R, Buchwald D. Single-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome. Psychosom Med. (2003) 65:129&#x2013;36. 10.1097/01.psy.0000038942.33335.9b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.psy.0000038942.33335.9b</ArticleId><ArticleId IdType="pubmed">12554824</ArticleId></ArticleIdList></Reference><Reference><Citation>Razumovsky A, DeBusk K, Calkins H, Snader S, Lucas K, Vyas P, et al. Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome. J Neuroimag. (2003) 13:57&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">12593133</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiuchi K, Farkas J, Natelson B. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging. (2006) 26:83&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16494597</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart J, Medow M, Messer Z, Baugham I, Terilli C, Ocon A. Postural neurocognitive and neuronal activated cerebral blood flow deficits in young chronic fatigue syndrome patients with postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. (2012) 302:1185&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3311460</ArticleId><ArticleId IdType="pubmed">22180650</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B, Mao X, Stegner A, Lange G, Vu D, Blate M, et al. Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity. J Neurol Sci. (2017) 375:411&#x2013;6. 10.1016/j.jns.2017.02.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.02.046</ArticleId><ArticleId IdType="pmc">PMC5393352</ArticleId><ArticleId IdType="pubmed">28320179</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswal B, Kunwar P, Natelson B. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J Neurol Sci. (2011) 301:9&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139492</ArticleId><ArticleId IdType="pubmed">21167506</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkelmeyer A, He J, Maclachlan L, Blamire A, Newton J. Intracranial compliance is associated with symptoms of orthostatic intolerance in chronic fatigue syndrome. PLos One. (2018) 13:e0200068. 10.1371/journal.pone.0200068</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0200068</ArticleId><ArticleId IdType="pmc">PMC6029803</ArticleId><ArticleId IdType="pubmed">29969498</ArticleId></ArticleIdList></Reference><Reference><Citation>Boissoneault J, Letzen J, Robinson M, Staud R. Cerebral blood flow and heart rate variability predict fatigue severity in patients with chronic fatigue syndrome. Brain Imaging Behav. (2018) 13:789&#x2013;97. 10.1007/s11682-018-9897-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-018-9897-x</ArticleId><ArticleId IdType="pmc">PMC6274602</ArticleId><ArticleId IdType="pubmed">29855991</ArticleId></ArticleIdList></Reference><Reference><Citation>Staud R, Boissoneault J, Craggs J, Lai S, Robinson M. Task related cerebral blood flow changes of patients with chronic fatigue syndrome: an arterial spin labeling study. Fatigue. (2018) 6:63&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5914525</ArticleId><ArticleId IdType="pubmed">29707427</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Julin P, Li T. Limbic perfusion is reduced in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Tomography. (2021) 7:675&#x2013;87. 10.3390/tomography7040056</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tomography7040056</ArticleId><ArticleId IdType="pmc">PMC8628916</ArticleId><ArticleId IdType="pubmed">34842817</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Verheugt F, Rowe P, Visser F. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract. (2020) 5:50&#x2013;8. 10.1016/j.cnp.2020.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2020.01.003</ArticleId><ArticleId IdType="pmc">PMC7044650</ArticleId><ArticleId IdType="pubmed">32140630</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Rowe P, Visser F. Cerebral blood flow is reduced in severe myalgic encephalomyelitis/chronic fatigue syndrome patients during mild orthostatic stress testing: an exploratory study at 20 degrees of head-up tilt testing. Healthcare (Basel). (2020) 8:169. 10.3390/healthcare8020169</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8020169</ArticleId><ArticleId IdType="pmc">PMC7349207</ArticleId><ArticleId IdType="pubmed">32545797</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Visser F. Psychogenic pseudosyncope: real or imaginary? Results from a case-control study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients. Medicina (Kaunas). (2022) 58:98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8781940</ArticleId><ArticleId IdType="pubmed">35056406</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Rowe P, Visser F. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients. Clin Neurophysiol Pract. (2021) 6:245&#x2013;55. 10.1016/j.cnp.2021.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2021.09.001</ArticleId><ArticleId IdType="pmc">PMC8505270</ArticleId><ArticleId IdType="pubmed">34667909</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischler B, D&#x2019;Haenen H, Cluydts R, Michiels V, Demets K, Bossuyt A, et al. Comparison of 99mTc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology. (1996) 34:175&#x2013;83. 10.1159/000119307</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000119307</ArticleId><ArticleId IdType="pubmed">9121617</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfliet A, Pas R, Brouns R, De Win J, Hatem S, Meeus M, et al. Cerebral blood flow and heart rate variability in chronic fatigue syndrome: a randomized cross-over study. Pain Physician. (2018) 21:E13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">29357332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis D, Mayberg H, Fischer M, Goldberg J, Ashton S, Graham M, et al. Monozygotic twins discordant for chronic fatigue syndrome: regional cerebral blood flow SPECT. Radiology. (2001) 219:766&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">11376266</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Giannetti M, Weller E, Hamilton M, Mukerji S, Alabsi H, et al. Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndrome. Neurol Sci. (2022) 43:6627&#x2013;38. 10.1007/s10072-022-06423-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06423-y</ArticleId><ArticleId IdType="pmc">PMC9517969</ArticleId><ArticleId IdType="pubmed">36169757</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Visser F. Long-haul COVID patients: prevalence of POTS are reduced but cerebral blood flow abnormalities remain abnormal with longer disease duration. Healthcare (Basel). (2022) 10:2105. 10.3390/healthcare10102105</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10102105</ArticleId><ArticleId IdType="pmc">PMC9602558</ArticleId><ArticleId IdType="pubmed">36292552</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T, Wu J, Chen T, Li J, Yan S, Zhou Y, et al. Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations. JCI Insight. (2022) 7:e155827. 10.1172/jci.insight.155827</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.155827</ArticleId><ArticleId IdType="pmc">PMC8876627</ArticleId><ArticleId IdType="pubmed">35191397</ArticleId></ArticleIdList></Reference><Reference><Citation>Demitrack M, Dale J, Straus S, Laue L, Listwak S, Kruesi M, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab. (1991) 73:1224&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">1659582</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinan T. Neuroendocrinology of chronic fatigue syndrome. J Chronic Fatigue Syndrome. (1996) 2:69&#x2013;70.</Citation></Reference><Reference><Citation>Cleare A. The HPA axis and the genesis of chronic fatigue syndrome. TRENDS Endocrin Metabol. (2004) 15:55&#x2013;9. 10.1016/j.tem.2003.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2003.12.002</ArticleId><ArticleId IdType="pubmed">15036250</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A, Wessely S, Chalder T, Papadopoulos A, Cleare A. Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry. (2004) 184:136&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">14754825</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerjes W, Taylor N, Wood P, Cleare A. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology. (2007) 32:192&#x2013;8. 10.1016/j.psyneuen.2006.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2006.12.005</ArticleId><ArticleId IdType="pubmed">17276605</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Eede F, Moorkens G, Hulstijn W, van Houdenhove B, Cosyns P, Sabbe B, et al. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome. Psychol Med. (2008) 38:963&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">17803834</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller V, Vitelli V, Sulheim D, Fagermoen E, Winger A, Godang K, et al. Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study. J Transl Med. (2016) 14:121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4858924</ArticleId><ArticleId IdType="pubmed">27149955</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Anderson G, Maes M. Hypothalamic-pituitary-adrenal hypofunction in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Mol Neurobiol. (2017) 54:6806&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">27766535</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak L, Cleare A, Ormel J, Manoharan A, Kok I, Wessely S, et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol. (2011) 87:183&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">21315796</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell D, Liossi C, Moss-Morris R, Schlotz W. Unstimulated cortisol secretory activity in everyday life and its relationship with fatigue and chronic fatigue syndrome: a systematic review and subset meta-analysis. Psychoneuroendocrinology. (2013) 38:2405&#x2013;22. 10.1016/j.psyneuen.2013.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2013.07.004</ArticleId><ArticleId IdType="pubmed">23916911</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus M, Nijs J, Van de Wauwer N, Toeback L, Truijen S. Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: an experimental study. Pain. (2008) 139:439&#x2013;48. 10.1016/j.pain.2008.05.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2008.05.018</ArticleId><ArticleId IdType="pubmed">18617327</ArticleId></ArticleIdList></Reference><Reference><Citation>Inder W, Prickett T, Mulder R. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment. Clin Endocrinol. (2005) 62:343&#x2013;8. 10.1111/j.1365-2265.2005.02220.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02220.x</ArticleId><ArticleId IdType="pubmed">15730417</ArticleId></ArticleIdList></Reference><Reference><Citation>Urhan E, Karaca Z, Unuvar G, Gundogan K, Unluhizarci K. Investigation of pituitary functions after acute coronavirus disease 2019. Endocrine J. (2022) 69:649&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">34987144</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N, Nakano Y, Otsuka Y, Tokumasu K, Honda H, Sakurada Y, et al. Characteristics of sleep disturbance in patients with long COVID: a retrospective observational study in Japan. J Clin Med. (2022) 11:7332. 10.3390/jcm11247332</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247332</ArticleId><ArticleId IdType="pmc">PMC9783729</ArticleId><ArticleId IdType="pubmed">36555948</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N, Honda H, Nakano Y, Yamamoto K, Tokumasu K, Sakurada Y, et al. Hormonal trends in patients suffering from long COVID symptoms. Endocrine J. (2022) 69:1173&#x2013;81. 10.1507/endocrj.EJ22-0093</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0093</ArticleId><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamazaki K, Nishigaki T, Kuramoto N, Oh K, Konishi H. Secondary adrenal insufficiency after COVID-19 diagnosed by insulin tolerance test and corticotropin-releasing hormone test. Cureus. (2022) 14:e23021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8908067</ArticleId><ArticleId IdType="pubmed">35281581</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavropoulou M, Tsokos G, Chrousos G, Sfikakis P. Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID. Clin Immunol. (2022) 245:109133. 10.1016/j.clim.2022.109133</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109133</ArticleId><ArticleId IdType="pmc">PMC9519365</ArticleId><ArticleId IdType="pubmed">36182048</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke S, Phylactou M, Patel B, Mills E, Muzi B, Izzi-Engbeaya C, et al. Normal adrenal and thyroid function in patients who survive COVID-19 infection. J Clin Endocrinol Metab. (2021) 106:2208&#x2013;20. 10.1210/clinem/dgab349</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab349</ArticleId><ArticleId IdType="pmc">PMC8194556</ArticleId><ArticleId IdType="pubmed">34008009</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakheit A, Behan P, Dinan T, Gray C, O&#x2019;Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ. (1992) 304:1010&#x2013;2. 10.1136/bmj.304.6833.1010</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.304.6833.1010</ArticleId><ArticleId IdType="pmc">PMC1881733</ArticleId><ArticleId IdType="pubmed">1586780</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleare A, Bearn J, Allain T, McGregor A, Wessely S, Murray R, et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord. (1995) 35:283&#x2013;9. 10.1016/0165-0327(95)00026-j</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-0327(95)00026-j</ArticleId><ArticleId IdType="pubmed">8550954</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearn J, Allain T, Coskeran P, Munro N, Butler J, McGregor A, et al. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol Psychiatry. (1995) 37:245&#x2013;52. 10.1016/0006-3223(94)00121-I</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-3223(94)00121-I</ArticleId><ArticleId IdType="pubmed">7711161</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatham L, Morehouse R, Chisholm B, Haase D, MacDonald D, Marrie T. Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome. Can J Psychiatry. (1995) 40:93&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7788624</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassallo C, Feldman E, Peto T, Castell L, Sharpley A, Cowen P. Decreased tryptophan availability but normal post-synaptic 5-HT 2c receptor sensitivity in chronic fatigue syndrome. Psychol Med. (2001) 31:585&#x2013;91. 10.1017/s0033291701003580</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0033291701003580</ArticleId><ArticleId IdType="pubmed">11352361</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D, Umali J, Stene M. Insulin-like growth factor-I (somatomedin C) levels in chronic fatigue syndrome and fibromyalgia. J Rheumatol. (1996) 23:739&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">8730136</ArticleId></ArticleIdList></Reference><Reference><Citation>Allain T, Bearn J, Coskerman P, Jones J, Checkley A, Butler J, et al. Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry. (1997) 41:567&#x2013;73. 10.1016/s0006-3223(96)00074-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-3223(96)00074-1</ArticleId><ArticleId IdType="pubmed">9046989</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwaerts J, Moorkens G, Abs R. Secretion of growth hormone in patients with chronic fatigue syndrome. Growth Horm IGF Res. (1998) 8:127&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10990147</ArticleId></ArticleIdList></Reference><Reference><Citation>Moorkens G, Berwaerts J, Wynants H, Abs R. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clin Endocrinol. (2000) 53:99&#x2013;106. 10.1046/j.1365-2265.2000.01049.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2265.2000.01049.x</ArticleId><ArticleId IdType="pubmed">10931086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Nunez B, Tarasse R, Vogelaar E, Janneke Dijck-Brouwer DA, Muskiet FAJ. Higher prevalence of &#x201c;low T3 syndrome&#x201d; in patients with chronic fatigue syndrome: a case-control study. Front Endocrinol. (2018) 9:97. 10.3389/fendo.2018.00097</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00097</ArticleId><ArticleId IdType="pmc">PMC5869352</ArticleId><ArticleId IdType="pubmed">29615976</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Lin J, Sheriff S, Maudsley A, Younger J. Evidence of widespread metabolite abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. (2019) 14:562&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612467</ArticleId><ArticleId IdType="pubmed">30617782</ArticleId></ArticleIdList></Reference><Reference><Citation>Mairal E, Barberon B, Laine N, Coulange M, Guedj E. Reversible widespread brain 18F-FDG PET hypometabolism in chronic fatigue syndrome treated by hyperbaric oxygen therapy. Eur J Nucl Med Mol Imaging. (2021) 48:1680&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">33420913</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion J, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. (2021) 48:2823&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Verger A, Kas A, Dudouet P, Goehringer F, Salmon-Ceron D, Guedj E. Visual interpretation of brain hypometabolism related to neurological long COVID: a French multicentric experience. Eur J Nucl Med Mol Imaging. (2022) 49:3197&#x2013;202. 10.1007/s00259-022-05753-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05753-5</ArticleId><ArticleId IdType="pmc">PMC8941296</ArticleId><ArticleId IdType="pubmed">35320385</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehringer F, Bruyere A, Doyen M, Bevilacqua S, Charmillon A, Heyer S, et al. Brain (18)F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur J Nucl Med Mol Imaging. (2022) 50:1084&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9628394</ArticleId><ArticleId IdType="pubmed">36322190</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R, Cuffaro L, Capozza A, Rosci C, Maiorana N, Groppo E, et al. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19. J Neurol. (2023) 270:1823&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9873215</ArticleId><ArticleId IdType="pubmed">36692636</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini A, Carli G, Kiferle L, Piersanti P, Palumbo P, Morbelli S, et al. Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients. Eur J Nucl Med Mol Imaging. (2022) 50:90&#x2013;102. 10.1007/s00259-022-05942-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05942-2</ArticleId><ArticleId IdType="pmc">PMC9388976</ArticleId><ArticleId IdType="pubmed">35984451</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand A, Campion J, Lepine A, Bosdure E, Luciani L, Cammilleri S, et al. Similar patterns of [(18)F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series. Eur J Nucl Med Mol Imaging. (2022) 49:913&#x2013;20. 10.1007/s00259-021-05528-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05528-4</ArticleId><ArticleId IdType="pmc">PMC8376118</ArticleId><ArticleId IdType="pubmed">34414470</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K, Bech J, Henriksen A, Johnsen S, Podlekareva D, Marner L. Cerebral metabolic rate of glucose and cognitive tests in long COVID patients. Brain Sci. (2022) 13:23. 10.3390/brainsci13010023</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13010023</ArticleId><ArticleId IdType="pmc">PMC9856023</ArticleId><ArticleId IdType="pubmed">36672005</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe P, Bou-Holaigah I, Kan J, Calkins H. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet. (1995) 345:623&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">7898182</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R, Komaroff A. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med. (1997) 102:357&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">9217617</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart J. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res. (2000) 48:218&#x2013;26. 10.1203/00006450-200008000-00016</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/00006450-200008000-00016</ArticleId><ArticleId IdType="pubmed">10926298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller V, Saul J, Amlie J, Thaulow E. Sympathetic predominance of cardiovascular regulation during mild orthostatic stress in adolescents with chronic fatigue. Clin Physiol Funct Imaging. (2007) 27:231&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17564672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller V, Barbieri R, Thaulow E, Saul J. Enhanced vagal withdrawal during mild orthostatic stress in adolescents with chronic fatigue. Ann Noninvasive Electrocardiol. (2008) 13:67&#x2013;73. 10.1111/j.1542-474X.2007.00202.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1542-474X.2007.00202.x</ArticleId><ArticleId IdType="pmc">PMC6932180</ArticleId><ArticleId IdType="pubmed">18234008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM. (2008) 101:961&#x2013;5. 10.1093/qjmed/hcn123</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcn123</ArticleId><ArticleId IdType="pubmed">18805903</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller V, Barbieri R, Saul J. Blood pressure variability and closed-loop baroreflex assessment in adolescent chronic fatigue syndrome during supine rest and orthostatic stress. Eur J Appl Physiol. (2011) 497:507. 10.1007/s00421-010-1670-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-010-1670-9</ArticleId><ArticleId IdType="pmc">PMC3037975</ArticleId><ArticleId IdType="pubmed">20890710</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Cauwenbergh D, Nijs J, Kos D, Van Weijnen L, Struyf F, Meeus M. Malfunctioning of the autonomic nervous system in patients with chronic fatigue syndrome: a systematic literature review. Eur J Clin Invest. (2014) 44:516&#x2013;26. 10.1111/eci.12256</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12256</ArticleId><ArticleId IdType="pubmed">24601948</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnden L, Kwiatek R, Crouch B, Burnet R, Del Fante P. Autonomic correlations with MRI are abnormal in the brainstem vasomotor centre in chronic fatigue syndrome. Neuroimage Clin. (2016) 11:530&#x2013;7. 10.1016/j.nicl.2016.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.03.017</ArticleId><ArticleId IdType="pmc">PMC4833047</ArticleId><ArticleId IdType="pubmed">27114901</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosterwijck J, Marusic U, De Wandele I, Paul L, Meeus M, Moorkens G, et al. The role of autonomic function in exercise-induced endogenous analgesia: a case-control study in myalgic encephalomyelitis/chronic fatigue syndrome and healthy people. Pain Physician. (2017) 20:E389&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">28339438</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M, Bahl J, Buckley J, Thomson R, Davison K. Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis. Medicine (Baltimore). (2019) 98:e17600. 10.1097/MD.0000000000017600</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000017600</ArticleId><ArticleId IdType="pmc">PMC6824690</ArticleId><ArticleId IdType="pubmed">31651868</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuong Q, Allison J, Finkelmeyer A, Newton J, Durham J. Brain responses in CFS and TMD to autonomic challenges: an exploratory fMRI study. JDR Clin Trans Res. (2020) 5:224&#x2013;32. 10.1177/2380084419872135</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2380084419872135</ArticleId><ArticleId IdType="pubmed">31461628</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oosterwijck J, Marusic U, De Wandele I, Meeus M, Paul L, Lambrecht L, et al. Reduced parasympathetic reactivation during recovery from exercise in myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Med. (2021) 10:4527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8509376</ArticleId><ArticleId IdType="pubmed">34640544</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B, Lin J, Blate M, Khan S, Chen Y, Unger E. Physiological assessment of orthostatic intolerance in chronic fatigue syndrome. J Transl Med. (2022) 20:95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8849016</ArticleId><ArticleId IdType="pubmed">35172863</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon S, Funk S, Bateman L, Stoddard G, Hammer S, Sullivan K, et al. Orthostatic challenge causes distinctive symptomatic, hemodynamic and cognitive responses in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. Front Med. (2022) 9:917019. 10.3389/fmed.2022.917019</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.917019</ArticleId><ArticleId IdType="pmc">PMC9285104</ArticleId><ArticleId IdType="pubmed">35847821</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa K. Orthostatic intolerance and chronotropic incompetence in patients with myalgic encephalomyelitis or chronic fatigue syndrome. Circ Rep. (2023) 5:55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9908528</ArticleId><ArticleId IdType="pubmed">36818521</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones J, Nicholson A, Nisenbaum R, Papanicolaou D, Solomon L, Boneva R, et al. Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med. (2005) 118:1415.e19&#x2013;e28.</Citation><ArticleIdList><ArticleId IdType="pubmed">16378795</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev. (2022) 21:103071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8848724</ArticleId><ArticleId IdType="pubmed">35182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D. The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res. (2020) 30:299&#x2013;315. 10.1007/s10286-020-00714-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00714-0</ArticleId><ArticleId IdType="pmc">PMC7374073</ArticleId><ArticleId IdType="pubmed">32700055</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N, Le Guen M, Russel S, Touche P, Huang F, Vallee A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep. (2021) 11:14042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranyo J, Bazan V, Llados G, Dominguez M, Bisbal F, Massanella M, et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep. (2022) 12:298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques K, Silva C, Trindade S, Santos M, Rocha R, Vasconcelos P, et al. Reduction of cardiac autonomic modulation and increased sympathetic activity by heart rate variability in patients with long COVID. Front Cardiovasc Med. (2022) 9:862001. 10.3389/fcvm.2022.862001</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.862001</ArticleId><ArticleId IdType="pmc">PMC9098798</ArticleId><ArticleId IdType="pubmed">35571200</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Visser F. Orthostatic intolerance in long-haul COVID after SARS-CoV-2: a case-control comparison with post-EBV and insidious-onset myalgic encephalomyelitis/chronic fatigue syndrome patients. Healthcare (Basel). (2022) 10:2058. 10.3390/healthcare10102058</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10102058</ArticleId><ArticleId IdType="pmc">PMC9602265</ArticleId><ArticleId IdType="pubmed">36292504</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci. (2020) 21:100276. 10.1016/j.ensci.2020.100276</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2020.100276</ArticleId><ArticleId IdType="pmc">PMC7502253</ArticleId><ArticleId IdType="pubmed">32984564</ArticleId></ArticleIdList></Reference><Reference><Citation>Petracek L, Suskauer S, Vickers R, Patel N, Violand R, Swope R, et al. Adolescent and young adult ME/CFS after confirmed or probable COVID-19. Front Med. (2021) 8:668944. 10.3389/fmed.2021.668944</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.668944</ArticleId><ArticleId IdType="pmc">PMC8116546</ArticleId><ArticleId IdType="pubmed">33996867</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R. Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor&#x2019;s page series. J Thromb Thrombolysis. (2021) 52:692&#x2013;707. 10.1007/s11239-021-02549-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02549-6</ArticleId><ArticleId IdType="pmc">PMC8367772</ArticleId><ArticleId IdType="pubmed">34403043</ArticleId></ArticleIdList></Reference><Reference><Citation>Koren T, Yifa R, Amer M, Krot M, Boshnak N, Ben-Shaanan T, et al. Insular cortex neurons encode and retrieve specific immune responses. Cell. (2021) 184:5902&#x2013;15.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">34752731</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A, Furlanis G, Frezza N, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and without neurological symptoms: a prospective multidomain observational study. J Neurol. (2022) 269:587&#x2013;96. 10.1007/s00415-021-10735-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinsvik E, Hausken T, Fluge O, Mella O, Gilja O. Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. Scand J Gastroenterol. (2023). Online ahead of print. 10.1080/00365521.2023.2173533</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365521.2023.2173533</ArticleId><ArticleId IdType="pubmed">36728717</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D, Cheney P, Peterson D, Henry B, Wormsley S, Geiger A, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med. (1992) 116:103&#x2013;13. 10.7326/0003-4819-116-2-103</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-116-2-103</ArticleId><ArticleId IdType="pubmed">1309285</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B, Cohen J, Brassloff I, Lee HJ. A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J Neurosurg Sci. (1993) 120:213&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8138812</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz R, Garada B, Komaroff A, Tice H, Gleit M, Jolesz F, et al. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. AJR Am J Roentgenol. (1994) 162:935&#x2013;41. 10.2214/ajr.162.4.8141020</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/ajr.162.4.8141020</ArticleId><ArticleId IdType="pubmed">8141020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange G, DeLuca J, Maldjian J, Lee H, Tiersky L, Natelson B. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurosci. (1999) 171:3&#x2013;7. 10.1016/s0022-510x(99)00243-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00243-9</ArticleId><ArticleId IdType="pubmed">10567042</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnden L, Crouch B, Kwiatek R, Burnet R, Mernone A, Chryssidis S, et al. A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis. NMR Biomed. (2011) 24:1302&#x2013;12. 10.1002/nbm.1692</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1692</ArticleId><ArticleId IdType="pmc">PMC4369126</ArticleId><ArticleId IdType="pubmed">21560176</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnden L, Shan Z, Staines D, Marshall-Gradisnik S, Finegan K, Ireland T, et al. Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome. Neuroimage Clin. (2018) 20:102&#x2013;9. 10.1016/j.nicl.2018.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.07.011</ArticleId><ArticleId IdType="pmc">PMC6309570</ArticleId><ArticleId IdType="pubmed">30497131</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D, Lange G, DeLuca J, Natelson B. Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int J Neurosci. (2001) 107:1&#x2013;6. 10.3109/00207450109149754</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207450109149754</ArticleId><ArticleId IdType="pubmed">11328679</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Embleton K, Pentreath V, Jackson A. Longitudinal MRI shows no cerebral abnormality in chronic fatigue syndrome. Br J Radiol. (2010) 83:419&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3473570</ArticleId><ArticleId IdType="pubmed">20223910</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F, Palladini M, Paolini M, Melloni E, Vai B, De Lorenzo R, et al. Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: a multimodal magnetic resonance imaging study. Brain Behav Immun Health. (2021) 18:100387. 10.1016/j.bbih.2021.100387</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100387</ArticleId><ArticleId IdType="pmc">PMC8562046</ArticleId><ArticleId IdType="pubmed">34746876</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti S, Paolini M, Mazza M, Palladini M, Furlan R, Querini P, et al. Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors. Eur Neuropsychopharmacol. (2022) 61:71&#x2013;7. 10.1016/j.euroneuro.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9239982</ArticleId><ArticleId IdType="pubmed">35810586</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine J, Schwichtenberg K, Hartung T, Rekers S, Chien C, Boesl F, et al. Structural brain changes in patients with post-COVID fatigue: a prospective observational study. eClinicalMedicine. (2023) 58:101874. 10.1016/j.eclinm.2023.101874</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101874</ArticleId><ArticleId IdType="pmc">PMC9969172</ArticleId><ArticleId IdType="pubmed">36873426</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineh M, Kang J, Atlas S, Raman M, Reiss A, Norris J, et al. Right arcuate fasciculus abnormality in chronic fatigue syndrome. Radiology. (2014) 274:517&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">25353054</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkelmeyer A, He J, Maclachlan L, Watson S, Gallagher P, Newton J, et al. Grey and white matter differences in chronic fatigue syndrome - a voxel-based morphometry study. Neuroimage Clin. (2018) 17:24&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633338</ArticleId><ArticleId IdType="pubmed">29021956</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapaliya K, Marshall-Gradisnik S, Staines D, Su J, Barnden L. Alteration of cortical volume and thickness in myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurosci. (2022) 16:848730. 10.3389/fnins.2022.848730</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.848730</ArticleId><ArticleId IdType="pmc">PMC9072664</ArticleId><ArticleId IdType="pubmed">35527811</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Z, Kwiatek R, Burnet R, Del Fante P, Staines D, Marshall-Gradisnik S, et al. Progressive brain changes in patients with chronic fatigue syndrome: a longitudinal MRI study. J Magn Reson Imaging. (2016) 44:1301&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111735</ArticleId><ArticleId IdType="pubmed">27123773</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol. (2004) 4:14. 10.1186/1471-2377-4-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-4-14</ArticleId><ArticleId IdType="pmc">PMC524491</ArticleId><ArticleId IdType="pubmed">15461817</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lange F, Kalkman J, Bleijenberg G, Hagoort P, van der Meer J, Toni I. Gray matter volume reduction in the chronic fatigue syndrome. NeuroImage. (2005) 26:777&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">15955487</ArticleId></ArticleIdList></Reference><Reference><Citation>Putra H, Park K, Yamashita F, Nakagawa Y, Murai T. Cerebral gray matter volume correlates with fatigue and varies between desk workers and non-desk workers. Front Behav Neurosci. (2022) 16:951754. 10.3389/fnbeh.2022.951754</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2022.951754</ArticleId><ArticleId IdType="pmc">PMC9520909</ArticleId><ArticleId IdType="pubmed">36187379</ArticleId></ArticleIdList></Reference><Reference><Citation>Besteher B, Machnik M, Troll M, Toepffer A, Zerekidze A, Rocktaschel T, et al. Larger gray matter volumes in neuropsychiatric long-COVID syndrome. Psychiatry Res. (2022) 317:114836. 10.1016/j.psychres.2022.114836</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114836</ArticleId><ArticleId IdType="pmc">PMC9444315</ArticleId><ArticleId IdType="pubmed">36087363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafiz R, Gandhi T, Mishra S, Prasad A, Mahajan V, Di X, et al. Higher limbic and basal ganglia volumes in surviving COVID-negative patients and the relations to fatigue. Neuroimage Rep. (2022) 2:100095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9040524</ArticleId><ArticleId IdType="pubmed">35496469</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein T. Cortical grey matter volume depletion links to neurological sequelae in post COVID-19 &#x201c;long haulers&#x201d;. BMC Neurol. (2023) 23:22. 10.1186/s12883-023-03049-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-023-03049-1</ArticleId><ArticleId IdType="pmc">PMC9843113</ArticleId><ArticleId IdType="pubmed">36647063</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oosterwijck J, Nijs J, Meeus M, Lefever I, Huybrechts L, Lambrecht L, et al. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J Intern Med. (2010) 268:265&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">20412374</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus M, Roussel N, Truijen S, Nijs J. Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study. J Rehabil Med. (2010) 42:884&#x2013;90. 10.2340/16501977-0595</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-0595</ArticleId><ArticleId IdType="pubmed">20878051</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus M, Nijs J, Huybrechts S, Truijen S. Evidence for generalized hyperalgesia in chronic fatigue syndrome. Clin Rheumatol. (2010) 29:393&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20077123</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J, Meeus M, Van Oosterwijck J, Ickmans K, Moorkens G, Hans G, et al. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest. (2012) 42:203&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">21793823</ArticleId></ArticleIdList></Reference><Reference><Citation>Collin S, Nijs J, Meeus M, Polli A, Willekens B, Ickmans K. Endogenous pain facilitation rather than inhibition differs between people with chronic fatigue syndrome, multiple sclerosis, and controls: an observational study. Pain Physician. (2017) 20:E489&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">28535557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke J, Wodehouse T, Clark L, Constantinou E, Kidd B, Langford R, et al. Central sensitisation in chronic fatigue syndrome and fibromyalgia; a case control study. J Psychosom Res. (2021) 150:110624.</Citation><ArticleIdList><ArticleId IdType="pubmed">34600309</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Rowe P, Verheugt F, Visser F. Orthostatic stress testing in myalgic encephalomyelitis/chronic fatigue syndrome patients with or without concomitant fibromyalgia: effects on pressure pain thresholds and temporal summation. Clin Exp Rheumatol. (2021) 39 Suppl:39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">32940215</ArticleId></ArticleIdList></Reference><Reference><Citation>Polli A, Van Oosterwijck J, Nijs J, Marusic U, De Wandele I, Paul L, et al. Relationship between exercise-induced oxidative stress changes and parasympathetic activity in chronic fatigue syndrome: an observational study in patients and healthy subjects. Clin Ther. (2019) 41:641&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">30665828</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. (2003) 335:151&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531455</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Rawaf H, Alghadir A, Gabr S. MicroRNAs as biomarkers of pain intensity in patients with chronic fatigue syndrome. Pain Pract. (2019) 19:848&#x2013;60. 10.1111/papr.12817</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.12817</ArticleId><ArticleId IdType="pubmed">31282597</ArticleId></ArticleIdList></Reference><Reference><Citation>Walitt B, Ceko M, Gracely J, Gracely R. Neuroimaging of central sensitivity syndromes: key insights from the scientific literature. Curr Rheumatol Rev. (2016) 12:55&#x2013;87. 10.2174/1573397112666151231111104</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573397112666151231111104</ArticleId><ArticleId IdType="pmc">PMC4785050</ArticleId><ArticleId IdType="pubmed">26717948</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacho-Hernandez J, Fernandez-de-Las-Penas C, Fuensalida-Novo S, Jimenez-Antona C, Ortega-Santiago R, Cigaran-Mendez M. Sleep quality mediates the effect of sensitization-associated symptoms, anxiety, and depression on quality of life in individuals with post-COVID-19 pain. Brain Sci. (2022) 12:1363. 10.3390/brainsci12101363</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12101363</ArticleId><ArticleId IdType="pmc">PMC9599807</ArticleId><ArticleId IdType="pubmed">36291297</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lange F, Kalkman J, Bleijenberg G, Hagoort P, van der Werf S, van der Meer J, et al. Neural correlates of the chronic fatigue syndrome&#x2013;an fMRI study. Brain. (2004) 127:1948&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">15240435</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M, Sadato N, Okada T, Mizuno K, Sasabe T, Tanabe H, et al. Reduced responsiveness is an essential feature of chronic fatigue syndrome: a fMRI study. BMC Neurol. (2006) 6:9. 10.1186/1471-2377-6-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-6-9</ArticleId><ArticleId IdType="pmc">PMC1397862</ArticleId><ArticleId IdType="pubmed">16504053</ArticleId></ArticleIdList></Reference><Reference><Citation>Caseras X, Mataix-Cols D, Giampietro V, Rimes K, Brammer M, Zelaya F, et al. Probing the working memory system in chronic fatigue syndrome: a functional magnetic resonance imaging study using the n-back task. Psychosom Med. (2006) 68:947&#x2013;55. 10.1097/01.psy.0000242770.50979.5f</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.psy.0000242770.50979.5f</ArticleId><ArticleId IdType="pubmed">17079703</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno K, Kawatani J, Tajima K, Sasaki A, Yoneda T, Komi M, et al. Low putamen activity associated with poor reward sensitivity in childhood chronic fatigue syndrome. Neuroimage Clin. (2016) 12:600&#x2013;6. 10.1016/j.nicl.2016.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.09.016</ArticleId><ArticleId IdType="pmc">PMC5043413</ArticleId><ArticleId IdType="pubmed">27709065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortinger L, Endestad T, Melinder A, Oie M, Sulheim D, Fagermoen E, et al. Emotional conflict processing in adolescent chronic fatigue syndrome: a pilot study using functional magnetic resonance imaging. J Clin Exp Neuropsychol. (2017) 39:355&#x2013;68. 10.1080/13803395.2016.1230180</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13803395.2016.1230180</ArticleId><ArticleId IdType="pubmed">27647312</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi B, Langley C, Crawley E, Thai N. Using structural and functional MRI as a neuroimaging technique to investigate chronic fatigue syndrome/myalgic encephalopathy: a systematic review. BMJ Open. (2020) 10:e031672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462162</ArticleId><ArticleId IdType="pubmed">32868345</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Arevalo C, Oliveira R, Faria-Urbina M, Felsenstein D, Oaklander A, et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. (2021) 160:642&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727854</ArticleId><ArticleId IdType="pubmed">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A, Mills A, Kelley M, Toran L, Smith B, Dalakas M, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm. (2022) 9:e1146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Mukerji S, Alabsi H, Systrom D, Marciano S, Felsenstein D, et al. Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann Neurol. (2022) 91:367&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams R, Simpson D, Navis A, Jette N, Zhou L, Shin S. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. (2022) 65:440&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitirgen G, Korkmaz C, Zamani A, Ozkagnici A, Zengin N, Ponirakis G, et al. Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID. Br J Ophthalmol. (2022) 106:1635&#x2013;41. 10.1136/bjophthalmol-2021-319450</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2021-319450</ArticleId><ArticleId IdType="pmc">PMC8359871</ArticleId><ArticleId IdType="pubmed">34312122</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy F, McAnulty G, McCreary M, Cuchural G, Komaroff ALEEG. spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients - A case control study. BMC Neurol. (2011) 11:82. 10.1186/1471-2377-11-82</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-82</ArticleId><ArticleId IdType="pmc">PMC3146818</ArticleId><ArticleId IdType="pubmed">21722376</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubega M, Ciringione L, Bertuccelli M, Paramento M, Sparacino G, Vianello A, et al. High-density EEG sleep correlates of cognitive and affective impairment at 12-month follow-up after COVID-19. Clin Neurophysiol. (2022) 140:126&#x2013;35. 10.1016/j.clinph.2022.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2022.05.017</ArticleId><ArticleId IdType="pmc">PMC9292469</ArticleId><ArticleId IdType="pubmed">35763985</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger E, Nisenbaum R, Moldofsky H, Cesta A, Sammut C, Reyes M, et al. Sleep assessment in a population-based study of chronic fatigue syndrome. BMC Neurol. (2004) 4:6. 10.1186/1471-2377-4-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-4-6</ArticleId><ArticleId IdType="pmc">PMC419502</ArticleId><ArticleId IdType="pubmed">15096280</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksoud R, Eaton-Fitch N, Matula M, Cabanas H, Staines D, Marshall-Gradisnik S. Systematic review of sleep characteristics in myalgic encephalomyelitis/chronic fatigue syndrome. Healthcare (Basel). (2021) 9:568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8150292</ArticleId><ArticleId IdType="pubmed">34065013</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy M. Circadian rhythm disruption in myalgic encephalomyelitis/chronic fatigue syndrome: implications for the post-acute sequelae of COVID-19. Brain Behav Immun Health. (2022) 20:100412. 10.1016/j.bbih.2022.100412</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100412</ArticleId><ArticleId IdType="pmc">PMC9019698</ArticleId><ArticleId IdType="pubmed">35465246</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed A, Andersen T, Radovic S, Del Fante P, Kwiatek R, Calhoun V, et al. Objective sleep measures in chronic fatigue syndrome patients: a systematic review and meta-analysis. Sleep Med Rev. (2023) 69:101771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281648</ArticleId><ArticleId IdType="pubmed">36948138</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura A, Oliveira D, Torres D, Tavares-Junior J, Nobrega P, Braga-Neto P, et al. Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome - a prospective cohort study. BMC Neurol. (2022) 22:417. 10.1186/s12883-022-02940-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02940-7</ArticleId><ArticleId IdType="pmc">PMC9643986</ArticleId><ArticleId IdType="pubmed">36352367</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudi H, Saffari M, Movahedi M, Sanaeinasab H, Rashidi-Jahan H, Pourgholami M, et al. A mediating role for mental health in associations between COVID-19-related self-stigma, PTSD, quality of life, and insomnia among patients recovered from COVID-19. Brain Behav. (2021) 11:e02138. 10.1002/brb3.2138</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2138</ArticleId><ArticleId IdType="pmc">PMC8119851</ArticleId><ArticleId IdType="pubmed">33811451</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzueta E, Perrin P, Yuksel D, Ramos-Usuga D, Kiss O, Iacovides S, et al. An international study of post-COVID sleep health. Sleep Health. (2022) 8:684&#x2013;90. 10.1016/j.sleh.2022.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleh.2022.06.011</ArticleId><ArticleId IdType="pmc">PMC9501615</ArticleId><ArticleId IdType="pubmed">36163137</ArticleId></ArticleIdList></Reference><Reference><Citation>Merikanto I, Dauvilliers Y, Chung F, Wing Y, De Gennaro L, Holzinger B, et al. Sleep symptoms are essential features of long-COVID - comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II). J Sleep Res. (2022):e13754. 10.1111/jsr.13754</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsr.13754</ArticleId><ArticleId IdType="pmc">PMC9874584</ArticleId><ArticleId IdType="pubmed">36208038</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein C, Kagan D, Rizvydeen M, Warshaw S, Troost J, Burgess H. The possibility of circadian rhythm disruption in long COVID. Brain Behav Immun Health. (2022) 23:100476. 10.1016/j.bbih.2022.100476</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100476</ArticleId><ArticleId IdType="pmc">PMC9153185</ArticleId><ArticleId IdType="pubmed">35663839</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch J, Rengasamy E, Watson C, Jansen K, Chakraborty S, Sundaram R, et al. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun. (2022) 4:fcab297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford G, Manning P, Newton J. Understanding muscle dysfunction in chronic fatigue syndrome. J Aging Res. (2016) 2016:2497348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4779819</ArticleId><ArticleId IdType="pubmed">26998359</ArticleId></ArticleIdList></Reference><Reference><Citation>Retornaz F, Rebaudet S, Stavris C, Jammes Y. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study. J Transl Med. (2022) 20:429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9509619</ArticleId><ArticleId IdType="pubmed">36153556</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaver-Krol E, Hermens H, Vermeulen R, Klaver M, Luyten H, Henriquez N, et al. Chronic fatigue syndrome: abnormally fast muscle fiber conduction in the membranes of motor units at low static force load. Clin Neurophysiol. (2021) 132:967&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">33639451</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. (2021) 19:162. 10.1186/s12967-021-02833-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType="pmc">PMC8058748</ArticleId><ArticleId IdType="pubmed">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Petter E, Scheibenbogen C, Linz P, Stehning C, Wirth K, Kuehne T, et al. Muscle sodium content in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. (2022) 20:580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9733289</ArticleId><ArticleId IdType="pubmed">36494667</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, et al. Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an11C-(R)-PK11195 PET study. J Nucl Med. (2014) 55:945&#x2013;50. 10.2967/jnumed.113.131045</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.113.131045</ArticleId><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H, Tremblay M, Bienzle D, Fischer J. The pathobiology of myalgic encephalomyelitis/chronic fatigue syndrome: the case for neuroglial failure. Front Cell Neurosci. (2022) 16:888232. 10.3389/fncel.2022.888232</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.888232</ArticleId><ArticleId IdType="pmc">PMC9124899</ArticleId><ArticleId IdType="pubmed">35614970</ArticleId></ArticleIdList></Reference><Reference><Citation>Godlewska B, Williams S, Emir U, Chen C, Sharpley A, Goncalves A, et al. Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla. Psychopharmacology (Berl). (2022) 239:163&#x2013;71. 10.1007/s00213-021-05986-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-021-05986-6</ArticleId><ArticleId IdType="pmc">PMC8770374</ArticleId><ArticleId IdType="pubmed">34609538</ArticleId></ArticleIdList></Reference><Reference><Citation>Raijmakers R, Roerink M, Keijmel S, Joosten L, Netea M, van der Meer J, et al. No signs of neuroinflammation in women with chronic fatigue syndrome or Q fever fatigue syndrome using the TSPO ligand [(11)C]-PK11195. Neurol Neuroimmunol Neuroinflamm. (2022) 9:e1113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611501</ArticleId><ArticleId IdType="pubmed">34815320</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiatkittikul P, Promteangtrong C, Kunawudhi A, Siripongsatian D, Siripongboonsitti T, Ruckpanich P, et al. Abnormality pattern of f-18 FDG PET whole body with functional MRI brain in post-acute COVID-19. Nucl Med Mol Imaging. (2022) 56:29&#x2013;41. 10.1007/s13139-021-00730-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13139-021-00730-6</ArticleId><ArticleId IdType="pmc">PMC8760088</ArticleId><ArticleId IdType="pubmed">35069924</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A, Lu P, Geraghty A, Song E, Lee M, Wood J, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. (2022) 185:2452&#x2013;68.e16. 10.1016/j.cell.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R, Berg P. High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders. Eur J Med Res. (1995) 1:21&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9392689</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Kuratsune H, Hidaka Y, Hakariya Y, Tatsumi K, Takano T, et al. Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med. (2003) 12:225&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">12851722</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto S, Ouchi Y, Nakatsuka D, Tahara T, Mizuno K, Tajima S, et al. Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor. PLos One. (2012) 7:e51515. 10.1371/journal.pone.0051515</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051515</ArticleId><ArticleId IdType="pmc">PMC3519853</ArticleId><ArticleId IdType="pubmed">23240035</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch L, Wittke K, et al. Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome. Brain Behav Immun. (2016) 52:32&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome &#x2013; evidence for an autoimmune disease. Autoimmun Rev. (2018) 17:601&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y, Ryabkova V, Scheibenbogen C, Brinth L, Martinez-Lavin M, Ikeda S, et al. Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clin Immunol. (2020) 214:108384. 10.1016/j.clim.2020.108384</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108384</ArticleId><ArticleId IdType="pubmed">32171889</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii H, Sato W, Kimura Y, Matsuda H, Ota M, Maikusa N, et al. Altered structural brain networks related to adrenergic/muscarinic receptor autoantibodies in chronic fatigue syndrome. J Neuroimaging. (2020) 30:822&#x2013;7. 10.1111/jon.12751</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12751</ArticleId><ArticleId IdType="pubmed">32609410</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K, Scheibenbogen C. A unifying hypothesis of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): recognitions from the finding of autoantibodies against ss2-adrenergic receptors. Autoimmun Rev. (2020) 19:102527. 10.1016/j.autrev.2020.102527</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType="pubmed">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarski M, Freitag H, Lorenz S, Becker S, Sotzny F, Bauer S, et al. Delineating the association between soluble CD26 and autoantibodies against G-protein coupled receptors, immunological and cardiovascular parameters identifies distinct patterns in post-infectious vs. non-infection-triggered myalgic encephalomyelitis/chronic fatigue syndrome. Front Immunol. (2021) 12:644548. 10.3389/fimmu.2021.644548</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.644548</ArticleId><ArticleId IdType="pmc">PMC8056217</ArticleId><ArticleId IdType="pubmed">33889154</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bellis A, Bellastella G, Pernice V, Cirillo P, Longo M, Maio A, et al. Hypothalamic-pituitary autoimmunity and related impairment of hormone secretions in chronic fatigue syndrome. J Clin Endocrinol Metab. (2021) 106:e5147&#x2013;55. 10.1210/clinem/dgab429</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab429</ArticleId><ArticleId IdType="pubmed">34254637</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H, Szklarski M, Lorenz S, Sotzny F, Bauer S, Philippe A, et al. Autoantibodies to vasoregulative G-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Med. (2021) 10:3675. 10.3390/jcm10163675</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163675</ArticleId><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C, Mardin C, Lucio M, Wallukat G, Hoffmanns J, Schroder T, et al. Long COVID: association of functional autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation. Int J Mol Sci. (2022) 23:7209. 10.3390/ijms23137209</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B, Namkoong K, Kim J, Lee S, Yoon K, Choi M, et al. Altered resting-state functional connectivity in women with chronic fatigue syndrome. Psychiatry Res. (2015) 234:292&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26602611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortinger L, Endestad T, Melinder A, Oie M, Sevenius A, Bruun Wyller V. Aberrant resting-state functional connectivity in the salience network of adolescent chronic fatigue syndrome. PLos One. (2016) 11:e0159351. 10.1371/journal.pone.0159351</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0159351</ArticleId><ArticleId IdType="pmc">PMC4944916</ArticleId><ArticleId IdType="pubmed">27414048</ArticleId></ArticleIdList></Reference><Reference><Citation>Gay C, Robinson M, Lai S, O&#x2019;Shea A, Craggs J, Price D, et al. Abnormal resting-state functional connectivity in patients with chronic fatigue syndrome: results of seed and data-driven analyses. Brain Connect. (2016) 6:48&#x2013;56. 10.1089/brain.2015.0366</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/brain.2015.0366</ArticleId><ArticleId IdType="pmc">PMC4744887</ArticleId><ArticleId IdType="pubmed">26449441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinn M, Zinn M, Jason L. Intrinsic functional hypoconnectivity in core neurocognitive networks suggests central nervous system pathology in patients with myalgic encephalomyelitis: a pilot study. Appl Psychophysiol Biofeedback. (2016) 41:283&#x2013;300. 10.1007/s10484-016-9331-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10484-016-9331-3</ArticleId><ArticleId IdType="pubmed">26869373</ArticleId></ArticleIdList></Reference><Reference><Citation>Boissoneault J, Letzen J, Lai S, O&#x2019;Shea A, Craggs J, Robinson M, et al. Abnormal resting state functional connectivity in patients with chronic fatigue syndrome: an arterial spin-labeling fMRI study. Magn Reson Imaging. (2016) 34:603&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4801728</ArticleId><ArticleId IdType="pubmed">26708036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortinger L, Glenne Oie M, Endestad T, Bruun Wyller V. Altered right anterior insular connectivity and loss of associated functions in adolescent chronic fatigue syndrome. PLos One. (2017) 12:e0184325. 10.1371/journal.pone.0184325</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184325</ArticleId><ArticleId IdType="pmc">PMC5589232</ArticleId><ArticleId IdType="pubmed">28880891</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Z, Finegan K, Bhuta S, Ireland T, Staines D, Marshall-Gradisnik S, et al. Decreased connectivity and increased blood oxygenation level dependent complexity in the default mode network in individuals with chronic fatigue syndrome. Brain Connect. (2018) 8:33&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29152994</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnden L, Shan Z, Staines D, Marshall-Gradisnik S, Finegan K, Ireland T, et al. Intra brainstem connectivity is impaired in chronic fatigue syndrome. Neuroimage Clin. (2019) 24:102045. 10.1016/j.nicl.2019.102045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102045</ArticleId><ArticleId IdType="pmc">PMC6835065</ArticleId><ArticleId IdType="pubmed">31671321</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinn M, Jason L. Cortical autonomic network connectivity predicts symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Int J Psychophysiol. (2021) 170:89&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">34662673</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson T, Zhang L, Guo H, Nacul L, Song X. Brainstem abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: a scoping review and evaluation of magnetic resonance imaging findings. Front Neurol. (2021) 12:769511. 10.3389/fneur.2021.769511</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.769511</ArticleId><ArticleId IdType="pmc">PMC8718708</ArticleId><ArticleId IdType="pubmed">34975729</ArticleId></ArticleIdList></Reference><Reference><Citation>Josev E, Malpas C, Seal M, Scheinberg A, Lubitz L, Rowe K, et al. Resting-state functional connectivity, cognition, and fatigue in response to cognitive exertion: a novel study in adolescents with chronic fatigue syndrome. Brain Imaging Behav. (2019) 14:1815&#x2013;30. 10.1007/s11682-019-00119-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-019-00119-2</ArticleId><ArticleId IdType="pubmed">31102168</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk J, Casado B, Maibach H, Clauw D, Pannell L, Hess S. A chronic fatigue syndrome-related proteome in human cerebrospinal fluid. BMC Neurol. (2005) 5:22. 10.1186/1471-2377-5-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-5-22</ArticleId><ArticleId IdType="pmc">PMC1326206</ArticleId><ArticleId IdType="pubmed">16321154</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutzer S, Angel T, Liu T, Schepmoes A, Clauss T, Adkins J, et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLos One. (2011) 6:e17287. 10.1371/journal.pone.0017287</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017287</ArticleId><ArticleId IdType="pmc">PMC3044169</ArticleId><ArticleId IdType="pubmed">21383843</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, Kortvelyessy P, Jelcic I, Stettner M, Franciotta D, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflamm. (2022) 19:19. 10.1186/s12974-021-02339-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, Goereci Y, Franke C, Silling S, Bosl F, Maier F, et al. Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Ann Neurol. (2022) 91:150&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Preez S, Eaton-Fitch N, Cabanas H, Staines D, Marshall-Gradisnik S. Characterization of IL-2 stimulation and TRPM7 pharmacomodulation in NK cell cytotoxicity and channel co-localization with PIP2 in myalgic encephalomyelitis/chronic fatigue syndrome patients. Int J Environ Res Public Health. (2021) 18:11879. 10.3390/ijerph182211879</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182211879</ArticleId><ArticleId IdType="pmc">PMC8618557</ArticleId><ArticleId IdType="pubmed">34831634</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Preez S, Cabanas H, Staines D, Marshall-Gradisnik S. Potential implications of mammalian transient receptor potential melastatin 7 in the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome: a review. Int J Environ Res Public Health. (2021) 18:10708. 10.3390/ijerph182010708</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182010708</ArticleId><ArticleId IdType="pmc">PMC8535478</ArticleId><ArticleId IdType="pubmed">34682454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasso E, Muraki K, Eaton-Fitch N, Smith P, Lesslar O, Deed G, et al. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients. Mol Med. (2022) 28:98. 10.1186/s10020-022-00528-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00528-y</ArticleId><ArticleId IdType="pmc">PMC9388968</ArticleId><ArticleId IdType="pubmed">35986236</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk J. Review of the midbrain ascending arousal network nuclei and implications for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Gulf War Illness (GWI) and postexertional malaise (PEM). Brain Sci. (2022) 12:132. 10.3390/brainsci12020132</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12020132</ArticleId><ArticleId IdType="pmc">PMC8870178</ArticleId><ArticleId IdType="pubmed">35203896</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapaliya K, Marshall-Gradisnik S, Barth M, Eaton-Fitch N, Barnden L. Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients. Front Neurosci. (2023) 17:1125208. 10.3389/fnins.2023.1125208</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1125208</ArticleId><ArticleId IdType="pmc">PMC10017877</ArticleId><ArticleId IdType="pubmed">36937672</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. (2021) 12:573&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M, Sans H, Forman C, Nylander A, Ho H, Lu S, et al. Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. (2022) 9:e200003. 10.1212/NXI.0000000000200003</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200003</ArticleId><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol. (1987) 139:3306&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">2824604</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas N, Salvato F, Morgan R, Fletcher M. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. (1990) 28:1403&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC267940</ArticleId><ArticleId IdType="pubmed">2166084</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki T, Miyakoshi H, Usuda Y, Herberman R. Low NK syndrome and its relationship to chronic fatigue syndrome. Clin Immunol Immunopathol. (1993) 69:253&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">8242898</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Thrasher J. Cellular and humoral immune abnormalities in Gulf War veterans. Environ Health Perspect. (2004) 112:840&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1242010</ArticleId><ArticleId IdType="pubmed">15175170</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E, van Driel M, Straines D, Ashton K, Hardcastle S, Keane J, et al. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. (2012) 10:88. 10.1186/1479-5876-10-88</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-10-88</ArticleId><ArticleId IdType="pmc">PMC3464733</ArticleId><ArticleId IdType="pubmed">22571715</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E, Huth T, Hardcastle S, Fuller K, Kaur M, Johnston S, et al. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Int Immunol. (2014) 26:233&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">24343819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardcastle S, Brenu E, Johnston S, Nguyen T, Huth T, Kaur M, et al. Analysis of the relationship between immune dysfunction and symptom severity in patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Clin Cell Immunol. (2014) 5:1000190.</Citation></Reference><Reference><Citation>Chacko A, Staines D, Johnston S, Marshall-Gradisnik S. Dysregulation of protein kinase gene expression in NK cells from chronic fatigue syndrome/myalgic encephalomyelitis patients. Gene Regul Syst Bio. (2016) 10:85&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003121</ArticleId><ArticleId IdType="pubmed">27594784</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth T, Brenu E, Ramos S, Nguyen T, Broadley S, Staines D, et al. Pilot study of natural killer cells in chronic fatigue syndrome/myalgic encephalomyelitis and multiple sclerosis. Scand J Immunol. (2016) 83:44&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">26381393</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Johnston S, Clarke L, Smith P, Staines D, Marshall-Gradisnik S. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels. Clin Exp Immunol. (2017) 187:284&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5217865</ArticleId><ArticleId IdType="pubmed">27727448</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas J, Palencia T, Fernandez G, Garcia M. Association of T and NK cell phenotype with the diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Front Immunol. (2018) 9:1028. 10.3389/fimmu.2018.01028</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01028</ArticleId><ArticleId IdType="pmc">PMC5954087</ArticleId><ArticleId IdType="pubmed">29867995</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Staines D, Johnston S, Marshall-Gradisnik S. Reduced glycolytic reserve in isolated natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients: a preliminary investigation. Asian Pac J Allergy Immunol. (2019) 37:102&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29981562</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton-Fitch N, du Preez S, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome. Syst Rev. (2019) 8:279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857215</ArticleId><ArticleId IdType="pubmed">31727160</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung A, Tang J, Guglielmo M, Smith-Gagen J, Bateman L, Navarrete-Galvan L, et al. Antibody-dependent cell-mediated cytotoxicity (ADCC) in familial myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Fatigue. (2021) 8:226&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993113</ArticleId><ArticleId IdType="pubmed">33777500</ArticleId></ArticleIdList></Reference><Reference><Citation>Theorell J, Bileviciute-Ljungar I, Tesi B, Schlums H, Johnsgaard M, Asadi-Azarbaijani B, et al. Unperturbed cytotoxic lymphocyte phenotype and function in myalgic encephalomyelitis/chronic fatigue syndrome patients. Front Immunol. (2017) 8:723. 10.3389/fimmu.2017.00723</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00723</ArticleId><ArticleId IdType="pmc">PMC5483846</ArticleId><ArticleId IdType="pubmed">28694809</ArticleId></ArticleIdList></Reference><Reference><Citation>Cliff J, King E, Lee J, Sepulveda N, Wolf A, Kingdon C, et al. Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Front Immunol. (2019) 10:796. 10.3389/fimmu.2019.00796</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00796</ArticleId><ArticleId IdType="pmc">PMC6477089</ArticleId><ArticleId IdType="pubmed">31057538</ArticleId></ArticleIdList></Reference><Reference><Citation>Galan M, Vigon L, Fuertes D, Murciano-Anton M, Casado-Fernandez G, Dominguez-Mateos S, et al. Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with long-COVID: identification of diagnostic biomarkers. Front Immunol. (2022) 13:848886. 10.3389/fimmu.2022.848886</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F, Hope C, Masavuli M, Lynn M, Mekonnen Z, Yeow A, et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. (2022) 20:26. 10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Montoya J, Klimas N, Levine S, Felsenstein D, Bateman L, et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. (2015) 1:e1400121. 10.1126/sciadv.1400121</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1400121</ArticleId><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett A, Chao C, Hu S, Buchwald D, Fagioli L, Schur P, et al. Elevation of bioactive transforming growth factor-B in serum from patients with chronic fatigue syndrome. J Clin Immunol. (1997) 17:160&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9083892</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss R, Mercandetti A, Vojdani AT. NF-&#x3b1; and chronic fatigue syndrome. J Clin Immunol. (1999) 19:314&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10535608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr J, Barah F, Mattey D, Laing I, Hopkins S, Hutchinson I, et al. Circulating tumour necrosis factor-&#x3b1; and interferon- g are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol. (2001) 82:3011&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11714978</ArticleId></ArticleIdList></Reference><Reference><Citation>Patarca R. Cytokines and chronic fatigue syndrome. Ann NY Acad Sci. (2001) 933:185&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">12000020</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher M, Zeng X, Barnes Z, Levis S, Klimas N. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. (2009) 7:96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2779802</ArticleId><ArticleId IdType="pubmed">19909538</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick G, Fuite J, Kreitz A, Vernon S, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun. (2010) 24:1209&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2939140</ArticleId><ArticleId IdType="pubmed">20447453</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Twisk F, Ringel K. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom. (2012) 81:286&#x2013;95. 10.1159/000336803</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000336803</ArticleId><ArticleId IdType="pubmed">22832503</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringer E, Baker K, Carroll I, Montoya J, Chu L, Maecker H, et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J Transl Med. (2013) 11:93. 10.1186/1479-5876-11-93</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-11-93</ArticleId><ArticleId IdType="pmc">PMC3637529</ArticleId><ArticleId IdType="pubmed">23570606</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaiboullina S, DeMeirleir K, Rawat S, Berk G, Gaynor-Berk R, Mijatovic T, et al. Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis. Cytokine. (2015) 72:1&#x2013;8. 10.1016/j.cyto.2014.11.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.11.019</ArticleId><ArticleId IdType="pmc">PMC4410698</ArticleId><ArticleId IdType="pubmed">25514671</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink M, Knoop H, Bronkhorst E, Mouthaan H, Hawinkels L, Joosten L, et al. Cytokine signatures in chronic fatigue syndrome patients: a case control study and the effect of anakinra treatment. J Transl Med. (2017) 15:267. 10.1186/s12967-017-1371-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1371-9</ArticleId><ArticleId IdType="pmc">PMC5747240</ArticleId><ArticleId IdType="pubmed">29284500</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya J, Holmes T, Anderson J, Maecker H, Rosenberg-Hasson Y, Valencia I, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA. (2017) 114:E7150&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge R, Sartor M, Scott F, Cleare A. Inflammatory proteins are altered in chronic fatigue syndrome-A systematic review and meta-analysis. Neurosci Biobehav Rev. (2019) 107:69&#x2013;83. 10.1016/j.neubiorev.2019.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2019.08.011</ArticleId><ArticleId IdType="pubmed">31465778</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsj&#xf6; M, Olsson G, Wicksell R, Alving K, Holmstr&#xf6;m L, Andreasson A. The role of low-grade inflammation in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) - associations with symptoms. Psychoneuroendocrinology. (2020) 113:104578.</Citation><ArticleIdList><ArticleId IdType="pubmed">31901625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A, Maya J, Giloteaux L, Peterson D, Maynard M, Gottschalk C, et al. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J Clin Invest. (2020) 130:1491&#x2013;505. 10.1172/JCI132185</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132185</ArticleId><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Raanes E, Stiles T. Associations between psychological and immunological variables in chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review. Front Psychiatry. (2021) 12:716320. 10.3389/fpsyt.2021.716320</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.716320</ArticleId><ArticleId IdType="pmc">PMC8650213</ArticleId><ArticleId IdType="pubmed">34887782</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Gottschalk G, Peterson D, Knox K, Schultz A, Eddy M, et al. Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. Mol Psychiatry. (2016) 21:261&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25824300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Schwander S, Donnelly R, Ortega F, Togo F, Broderick G, et al. Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia. Clin Vaccine Immunol. (2010) 17:582&#x2013;7. 10.1128/CVI.00379-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00379-09</ArticleId><ArticleId IdType="pmc">PMC2849324</ArticleId><ArticleId IdType="pubmed">20181767</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark L, Buckland M, Murphy G, Taylor N, Vleck V, Mein C, et al. Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study. Clin Exp Immunol. (2017) 190:360&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5680051</ArticleId><ArticleId IdType="pubmed">28779554</ArticleId></ArticleIdList></Reference><Reference><Citation>Blundell S, Ray K, Buckland M, White P. Chronic fatigue syndrome and circulating cytokines: a systematic review. Brain Behav Immun. (2015) 50:186&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">26148446</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller V, Sorensen O, Sulheim D, Fagermoen E, Ueland T, Mollnes T. Plasma cytokine expression in adolescent chronic fatigue syndrome. Brain Behav Immun. (2015) 46:80&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25555530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashipaz M, Swinden D, Todd I, Powell R. Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol. (2003) 132:360&#x2013;5. 10.1046/j.1365-2249.2003.02149.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2003.02149.x</ArticleId><ArticleId IdType="pmc">PMC1808704</ArticleId><ArticleId IdType="pubmed">12699429</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker M, Brumfield S, Lara Mejia P. Neuroinflammation and cytokines in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods. Front Neurol. (2019) 9:1033. 10.3389/fneur.2018.01033</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01033</ArticleId><ArticleId IdType="pmc">PMC6335565</ArticleId><ArticleId IdType="pubmed">30687207</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbitt M, Eaton-Fitch N, Staines D, Cabanas H, Marshall-Gradisnik S. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID). BMC Neurol. (2019) 19:207. 10.1186/s12883-019-1433-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1433-0</ArticleId><ArticleId IdType="pmc">PMC6708220</ArticleId><ArticleId IdType="pubmed">31445522</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B, Guevara-Coto J, Yogendra R, Francisco E, Long E, Pise A, et al. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. (2021) 12:700782. 10.3389/fimmu.2021.700782</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S, et al. The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. (2022) 3:100663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa H, Shaw T, Knight S, Wemyss K, McClure F, Pearmain L, et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med (N Y). (2021) 2:720&#x2013;35.e4. 10.1016/j.medj.2021.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruenjaiman V, Sodsai P, Kueanjinda P, Bunrasmee W, Klinchanhom S, Reantragoon R, et al. Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery. J Microbiol Immunol Infect. (2022) 55(6 Pt 1):993&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9519362</ArticleId><ArticleId IdType="pubmed">36220753</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve D, Rojas M, Rodriguez Y, Zapata E, Ramirez-Santana C, et al. Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. J Infect Dis. (2022) 225:2155&#x2013;62. 10.1093/infdis/jiac017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Apostolo D, Albe A, Crevola M, Errica N, Ratano G, et al. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: a prospective cohort study. Front Immunol. (2022) 13:1038227. 10.3389/fimmu.2022.1038227</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1038227</ArticleId><ArticleId IdType="pmc">PMC9807078</ArticleId><ArticleId IdType="pubmed">36601115</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J, Serafini R, Pryce K, Zazhytska M, Oishi K, Golynker I, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery. Sci Trans Med. (2022) 14:eabq3059. 10.1126/scitranslmed.abq3059</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley D, Wilson D, Howe A, Munier C, Patel S, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. (2022) 23:210&#x2013;6. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Low R, Low R, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med. (2023) 10:1011936. 10.3389/fmed.2023.1011936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik J, Bileck A, Hagn G, Meier-Menches S, Frey T, Kaempf A, et al. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience. (2023) 26:105717. 10.1016/j.isci.2022.105717</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105717</ArticleId><ArticleId IdType="pmc">PMC9719844</ArticleId><ArticleId IdType="pubmed">36507225</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough E, Inigo J, Chandra D, Chaves L, Reynolds J, Aalinkeel R, et al. Mitochondrial dynamics in SARS-COV2 spike protein treated human microglia: implications for neuro-COVID. J Neuroimmune Pharmacol. (2021) 16:770&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8487226</ArticleId><ArticleId IdType="pubmed">34599743</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommen S, Havdal L, Selvakumar J, Einvik G, Leegaard T, Lund-Johansen F, et al. Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19. Front Immunol. (2023) 13:1081718. 10.3389/fimmu.2022.1081718</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1081718</ArticleId><ArticleId IdType="pmc">PMC9853911</ArticleId><ArticleId IdType="pubmed">36685555</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. (2023) 61:2200970. 10.1183/13993003.00970-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D, Buchwald D, Lee J, Doolittle T, Kornish J, Rutherford C, et al. Laboratory abnormalities in patients with chronic fatigue syndrome. Clin Infect Dis. (1994) 18(Suppl 1):S86&#x2013;S.</Citation></Reference><Reference><Citation>Clark M, Katon W, Russo J, Kith P, Sintay M, Buchwald D. Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am J Med. (1995) 88:187&#x2013;95. 10.1016/S0002-9343(99)80403-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(99)80403-3</ArticleId><ArticleId IdType="pubmed">7847436</ArticleId></ArticleIdList></Reference><Reference><Citation>Landay A, Jessop C, Lennette E, Levy J. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet. (1991) 338:707&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">1679864</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker E, Fujimura S, Fadem M, Landay A, Levy J. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. (1994) 18(Suppl. 1):S136&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">8148441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J, de Becker P, de Meirleir K, Demanet C, Vincken W, Schuermans D, et al. Associations between bronchial hyperresponsiveness and immune cell parameters in patients with chronic fatigue syndrome. Chest. (2003) 123:998&#x2013;1007. 10.1378/chest.123.4.998</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.123.4.998</ArticleId><ArticleId IdType="pubmed">12684286</ArticleId></ArticleIdList></Reference><Reference><Citation>Maya J, Leddy S, Gottschalk C, Peterson D, Hanson M. Altered fatty acid oxidation in lymphocyte populations of myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Sci. (2023) 24:2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9916395</ArticleId><ArticleId IdType="pubmed">36768336</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli U, Marotta G, Improta S, Pinto A. Immmunological abnormalities in patients with chronic fatigue syndrome. Scand J Immunol. (1994) 40:601&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7997849</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensah F, Bansal A, Berkovitz S, Sharma A, Reddy V, Leandro M, et al. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study. Clin Exp Immunol. (2016) 184:237&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4837232</ArticleId><ArticleId IdType="pubmed">26646713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensah F, Armstrong C, Reddy V, Bansal A, Berkovitz S, Leandro M, et al. CD24 expression and B cell maturation shows a novel link with energy metabolism: potential implications for patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Immunol. (2018) 9:2421. 10.3389/fimmu.2018.02421</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02421</ArticleId><ArticleId IdType="pmc">PMC6204382</ArticleId><ArticleId IdType="pubmed">30405620</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen C, Alsoe L, Lindvall J, Sulheim D, Fagermoen E, Winger A, et al. Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival. J Transl Med. (2017) 15:102. 10.1186/s12967-017-1201-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1201-0</ArticleId><ArticleId IdType="pmc">PMC5426002</ArticleId><ArticleId IdType="pubmed">28494812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunde S, Kristoffersen E, Sapkota D, Risa K, Dahl O, Bruland O, et al. Serum BAFF and APRIL Levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. PLos One. (2016) 11:e0161226. 10.1371/journal.pone.0161226</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0161226</ArticleId><ArticleId IdType="pmc">PMC4990178</ArticleId><ArticleId IdType="pubmed">27536947</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J, Fritz E, Kerr J, Cleare A, Wessely S, Mattey D. Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. J Clin Pathol. (2005) 58:860&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1770867</ArticleId><ArticleId IdType="pubmed">16049290</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlo-Stella N, Bozzini S, De Silvestri A, Sbarsi I, Pizzochero C, Lorusso L, et al. Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome. Int J Immunopathol Pharmacol. (2009) 22:745&#x2013;54. 10.1177/039463200902200320</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039463200902200320</ArticleId><ArticleId IdType="pubmed">19822091</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasi A, Bozzini S, Carlo-Stella N, Martinetti M, Bombardieri S, De Silvestri A, et al. Excess of activating killer cell immunoglobulin-like receptors and lack of HLA-Bw4 ligands: a two-edged weapon in chronic fatigue syndrome. Mol Med Rep. (2011) 4:535&#x2013;40. 10.3892/mmr.2011.447</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2011.447</ArticleId><ArticleId IdType="pubmed">21468604</ArticleId></ArticleIdList></Reference><Reference><Citation>Milivojevic M, Che X, Bateman L, Cheng A, Garcia B, Hornig M, et al. Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS. PLos One. (2020) 15:e0236148. 10.1371/journal.pone.0236148</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236148</ArticleId><ArticleId IdType="pmc">PMC7373296</ArticleId><ArticleId IdType="pubmed">32692761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato W, Ono H, Matsutani T, Nakamura M, Shin I, Amano K, et al. Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun. (2021) 95:245&#x2013;55. 10.1016/j.bbi.2021.03.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.03.023</ArticleId><ArticleId IdType="pubmed">33794313</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner S, Becker S, Hartwig J, Sotzny F, Lorenz S, Bauer S, et al. Autoimmunity-related risk variants in PTPN22 and CTLA4 are associated with ME/CFS with infectious onset. Front Immunol. (2020) 11:578. 10.3389/fimmu.2020.00578</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00578</ArticleId><ArticleId IdType="pmc">PMC7161310</ArticleId><ArticleId IdType="pubmed">32328064</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinov K, von Mikecz A, Buchwald D, Jones J, Gerace L, Tan E. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest. (1996) 98:1888&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC507629</ArticleId><ArticleId IdType="pubmed">8878441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikai M. Antinuclear antibodies in patients with chronic fatigue syndrome. Nippon Rinsho. (2007) 65:1067&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">17561698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokama Y, Empey-Campora C, Hara C, Higa N, Siu N, Lau R, et al. Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War and marine toxins. J Clin Lab Anal. (2008) 22:99&#x2013;105. 10.1002/jcla.20217</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.20217</ArticleId><ArticleId IdType="pmc">PMC6649096</ArticleId><ArticleId IdType="pubmed">18348309</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokama Y, Campora C, Hara C, Kuribayashi T, Huynh D, Yabusaki K. Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome. J Clin Lab Anal. (2009) 23:210&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6649060</ArticleId><ArticleId IdType="pubmed">19623655</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D, Wener M, Komaroff A. Anti-neuronal antibody levels in chronic fatigue syndrome patients with neurologic abnormalities. Arthritis Rheum. (1991) 34:1485&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1953828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabkova V, Gavrilova N, Poletaeva A, Pukhalenko A, Koshkina I, Churilov L, et al. Autoantibody correlation signatures in fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: association with symptom severity. Biomedicines. (2023) 11:257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9952981</ArticleId><ArticleId IdType="pubmed">36830795</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E, Mao T, Klein J, Dai Y, Huck J, Jaycox J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. (2021) 595:283&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, Furst J, Schulze-Rothe S, Wallukat A, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. (2021) 4:100100. 10.1016/j.jtauto.2021.100100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#x2019;Huillier A, Pagano S, Baggio S, Meyer B, Andrey D, Nehme M, et al. Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence. Eur J Clin Invest. (2022) 52:e13818. 10.1111/eci.13818</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13818</ArticleId><ArticleId IdType="pmc">PMC9348059</ArticleId><ArticleId IdType="pubmed">35598178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisareva E, Badiou S, Mihalovicova L, Mirandola A, Pastor B, Kudriavtsev A, et al. Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients. J Med Virol. (2023) 95:e28209. 10.1002/jmv.28209</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28209</ArticleId><ArticleId IdType="pmc">PMC9874393</ArticleId><ArticleId IdType="pubmed">36226380</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Filgueiras I, Kedor C, Freitag H, Wittke K, Bauer S, et al. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. Front Immunol. (2022) 13:981532. 10.3389/fimmu.2022.981532</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.981532</ArticleId><ArticleId IdType="pmc">PMC9552223</ArticleId><ArticleId IdType="pubmed">36238301</ArticleId></ArticleIdList></Reference><Reference><Citation>Seessle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. (2022) 74:1191&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui D, Lee C, Chow W, Lee A, Tam A, Pang P, et al. Long COVID in patients with mild to moderate disease: do thyroid function and autoimmunity play a role? Endocr Pract. (2021) 27:894&#x2013;902. 10.1016/j.eprac.2021.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2021.06.016</ArticleId><ArticleId IdType="pmc">PMC8257401</ArticleId><ArticleId IdType="pubmed">34237471</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody R, Sonda S, Johnston F, Smith K, Stephens N, McPherson M, et al. Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes. Front Immunol. (2022) 13:945021. 10.3389/fimmu.2022.945021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.945021</ArticleId><ArticleId IdType="pmc">PMC9403331</ArticleId><ArticleId IdType="pubmed">36032086</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M, Mitchell A, Wang C, Takahashi S, Hoh R, Tai V, et al. Low prevalence of interferon-&#x3b1; autoantibodies in people experiencing long COVID symptoms. J Infect Dis. (2023) 227:246&#x2013;50. 10.1093/infdis/jiac372</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac372</ArticleId><ArticleId IdType="pmc">PMC9494362</ArticleId><ArticleId IdType="pubmed">36089700</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Ghoneum M, Choppa P, Magtoto L, Lapp C. Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. J Intern Med. (1997) 242:465&#x2013;78. 10.1111/j.1365-2796.1997.tb00019.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.1997.tb00019.x</ArticleId><ArticleId IdType="pubmed">9437407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G, Spence V, Underwood C, Belch J. Increased neutrophil apoptosis in chronic fatigue syndrome. J Clin Pathol. (2004) 57:891&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1770396</ArticleId><ArticleId IdType="pubmed">15280416</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G, Khan F, Hill A, Underwood C, Belch J. Biochemical and vascular aspects of pediatric chronic fatigue syndrome. Arch Pediatr Adolesc Med. (2010) 164:817&#x2013;23. 10.1001/archpediatrics.2010.157</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpediatrics.2010.157</ArticleId><ArticleId IdType="pubmed">20819963</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang H, Xie Q, Boneva R, Fostel J, Perkins R, Tong W. Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics. (2006) 7:429&#x2013;40. 10.2217/14622416.7.3.429</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/14622416.7.3.429</ArticleId><ArticleId IdType="pubmed">16610953</ArticleId></ArticleIdList></Reference><Reference><Citation>Gow J, Hagan S, Herzyk P, Cannon C, Behan P, Chaudhuri A. A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics. (2009) 2:38. 10.1186/1755-8794-2-38</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8794-2-38</ArticleId><ArticleId IdType="pmc">PMC2716361</ArticleId><ArticleId IdType="pubmed">19555476</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu E, Ashton K, van Driel M, Staines D, Peterson D, Atkinson G, et al. Cytotoxic lymphocyte microRNAs as prospective biomarkers for chronic fatigue syndrome/myalgic encephalomyelitis. J Affect Disord. (2012) 141:261&#x2013;9. 10.1016/j.jad.2012.03.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2012.03.037</ArticleId><ArticleId IdType="pubmed">22572093</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Kleffmann T, Edgar C, de Lange M, Vallings R, Tate W. A SWATH-MS analysis of myalgic encephalomyelitis/chronic fatigue syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med. (2020) 18:365. 10.1186/s12967-020-02533-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02533-3</ArticleId><ArticleId IdType="pmc">PMC7512220</ArticleId><ArticleId IdType="pubmed">32972442</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahanbani F, Maynard R, Sing J, Jahanbani S, Perrino J, Spacek D, et al. Phenotypic characteristics of peripheral immune cells of myalgic encephalomyelitis/chronic fatigue syndrome via transmission electron microscopy: a pilot study. PLos One. (2022) 17:e0272703. 10.1371/journal.pone.0272703</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272703</ArticleId><ArticleId IdType="pmc">PMC9362953</ArticleId><ArticleId IdType="pubmed">35943990</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanink C, Vercoulen J, Galama J, Roos M, Meyaard L, van der Ven-Jongekrijg J, et al. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J Infect Dis. (1996) 173:460&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">8568312</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan I, Bannister B, Akbar A, Weir W, Bofill M. A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. Clin Immunol Immunopathol. (1998) 87:60&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576011</ArticleId></ArticleIdList></Reference><Reference><Citation>Schacterle R, Milford E, Komaroff A. The frequency of HLA class II antigens in chronic fatigue syndrome. J Chron Fatigue Synd. (2003) 11:33&#x2013;42.</Citation></Reference><Reference><Citation>Hajdarevic R, Lande A, Rekeland I, Rydland A, Strand E, Sosa D, et al. Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci. Brain Behav Immun. (2021) 98:101&#x2013;9. 10.1016/j.bbi.2021.08.219</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.08.219</ArticleId><ArticleId IdType="pubmed">34403736</ArticleId></ArticleIdList></Reference><Reference><Citation>Underhill J, Mahalingam M, Peakman M, Wessely S. Lack of association between HLA genotype and chronic fatigue syndrome. Eur J Immunogenet. (2001) 28:425&#x2013;8. 10.1046/j.1365-2370.2001.00235.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2370.2001.00235.x</ArticleId><ArticleId IdType="pubmed">11422420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos S, Brenu E, Broadley S, Kwiatek R, Ng J, Nguyen T, et al. Regulatory T, natural killer T and gammadelta T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison. Asian Pac J Allergy Immunol. (2016) 34:300&#x2013;5. 10.12932/AP0733</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP0733</ArticleId><ArticleId IdType="pubmed">27001659</ArticleId></ArticleIdList></Reference><Reference><Citation>Curriu M, Carillo J, Massanella M, Rigau J, Alegre J, Puig J, et al. Screening NK-, B- and T-cell phenotype and function in patients suffering from chronic fatigue syndrome. J Transl Med. (2013) 11:68. 10.1186/1479-5876-11-68</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-11-68</ArticleId><ArticleId IdType="pmc">PMC3614537</ArticleId><ArticleId IdType="pubmed">23514202</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Johnston S, Chacko A, Gibson D, Cepon J, Smith P, et al. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients. Asian Pac J Allergy Immunol. (2017) 35:75&#x2013;81. 10.12932/ap0771</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/ap0771</ArticleId><ArticleId IdType="pubmed">27362406</ArticleId></ArticleIdList></Reference><Reference><Citation>Balinas C, Nguyen T, Johnston S, Smith P, Staines D, Marshall-Gradisnik S. Investigation of mast cell toll-like receptor 3 in chronic fatigue syndrome/myalgic encephalomyelitis and systemic mastocytosis using the novel application of autoMACS magnetic separation and flow cytometry. Asian Pac J Allergy Immunol. (2018) 36:257&#x2013;64. 10.12932/AP-200517-0086</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP-200517-0086</ArticleId><ArticleId IdType="pubmed">29223146</ArticleId></ArticleIdList></Reference><Reference><Citation>Nepotchatykh E, Caraus I, Elremaly W, Leveau C, Elbakry M, Godbout C, et al. Circulating microRNA expression signatures accurately discriminate myalgic encephalomyelitis from fibromyalgia and comorbid conditions. Sci Rep. (2023) 13:1896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894933</ArticleId><ArticleId IdType="pubmed">36732593</ArticleId></ArticleIdList></Reference><Reference><Citation>Helliwell A, Stockwell P, Edgar C, Chatterjee A, Tate W. Dynamic epigenetic changes during a relapse and recovery cycle in myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Sci. (2022) 23:11852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9570248</ArticleId><ArticleId IdType="pubmed">36233152</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Liu Q, Zhang F, Lui G, Tso E, Yeoh Y, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. (2021) 70:276&#x2013;84. 10.1136/gutjnl-2020-322294</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322294</ArticleId><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi J, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. (2021) 591:639&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu X, Li J, Alter G, et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis. (2022) 76:e487&#x2013;e490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C, Goh D, Lim X, Tien T, Lim J, Lee J, et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. (2022) 71:226&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks E, Vance S, Dahlen A, Hedlin H, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (N Y). (2022) 3:371&#x2013;87.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, Catalan P, Rodriguez-Grande C, Adan J, Rodriguez-Gonzalez C, Munoz P, et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis. (2022) 22:211. 10.1186/s12879-022-07153-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus S, Tosato G, Armstrong G, Lawley T, Preble O, Henle W, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med. (1985) 102:7&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">2578268</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones J, Ray C, Minnich L, Hicks M, Kibler R, Lucas D. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med. (1985) 102:1&#x2013;7. 10.7326/0003-4819-102-1-</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-102-1-</ArticleId><ArticleId IdType="pubmed">2578266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wray B, Gaughf C, Chandler F, Jr., Berry S, Latham J, Wood L, et al. Detection of Epstein-Barr virus and cytomegalovirus in patients with chronic fatigue. Ann Allergy. (1993) 71:223&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8396863</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Luca D, Zorzenon M, Mirandola P, Colle R, Botta G, Cassai E. Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J Clin Microbiol. (1995) 33:1660&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC228240</ArticleId><ArticleId IdType="pubmed">7650209</ArticleId></ArticleIdList></Reference><Reference><Citation>Patnaik M, Komaroff A, Conley E, Ojo-Amaize E, Peter J. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis. (1995) 172:1364&#x2013;7. 10.1093/infdis/172.5.1364</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/172.5.1364</ArticleId><ArticleId IdType="pubmed">7594679</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol. (2006) 37(Suppl. 1):S39&#x2013;46. 10.1016/S1386-6532(06)70010-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(06)70010-5</ArticleId><ArticleId IdType="pubmed">17276367</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelle D, Barcy S, Huang M, Ashley R, Corey L, Zeh J, et al. Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome. Clin Infect Dis. (2002) 35:518&#x2013;25. 10.1086/341774</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/341774</ArticleId><ArticleId IdType="pubmed">12173124</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonnet A, Engelmann I, Moreau A, Garcia B, Six S, El Kalioubie A, et al. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now. (2021) 51:296&#x2013;9. 10.1016/j.idnow.2021.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC7816954</ArticleId><ArticleId IdType="pubmed">33495765</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B, Tancredi C, Song Y, Mogus A, Huang M, Zhu H, et al. Epstein-Barr virus and human herpesvirus-6 reactivation in acute COVID-19 patients. Viruses. (2022) 14:1872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9504756</ArticleId><ArticleId IdType="pubmed">36146679</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiee A, Teymouri Athar M, Amini M, Hajishah H, Siahvoshi S, Jalali M, et al. Reactivation of herpesviruses during COVID-19: a systematic review and meta-analysis. Rev Med Virol. (2023) 33:e2437.</Citation><ArticleIdList><ArticleId IdType="pubmed">36880642</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro V, Alves-Leon S, Sarmento D, Coelho W, Moreira O, Salvio A, et al. Herpesvirus and neurological manifestations in patients with severe coronavirus disease. Virol J. (2022) 19:101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9174631</ArticleId><ArticleId IdType="pubmed">35676707</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J, Okyay R, Licht W, Hurley D. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. (2021) 10:763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M, Deveau T, Munter S, Ryder D, Buck A, Beck-Engeser G, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. (2023) 133:e163669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L, Goodrich J, Walters W, Levine S, Ley R, Hanson M. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. (2016) 4:30. 10.1186/s40168-016-0171-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0171-4</ArticleId><ArticleId IdType="pmc">PMC4918027</ArticleId><ArticleId IdType="pubmed">27338587</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Williams B, Mishra N, Che X, Lee B, Bateman L, et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. (2017) 5:44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5405467</ArticleId><ArticleId IdType="pubmed">28441964</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Che X, Briese T, Ranjan A, Allicock O, Yates R, et al. Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS. Cell Host Microbe. (2023) 31:288&#x2013;304.e8. 10.1016/j.chom.2023.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2023.01.004</ArticleId><ArticleId IdType="pmc">PMC10183837</ArticleId><ArticleId IdType="pubmed">36758522</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong R, Gunter C, Fleming E, Vernon S, Bateman L, Unutmaz D, et al. Multi-&#x2019;omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients. Cell Host Microbe. (2023) 31:273&#x2013;87.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10353054</ArticleId><ArticleId IdType="pubmed">36758521</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y, Zuo T, Lui G, Zhang F, Liu Q, Li A, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. (2021) 70:698&#x2013;706. 10.1136/gutjnl-2020-323020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J, Bradley E, Zeamer A, Cincotta L, Salive M, Dutta P, et al. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight. (2021) 6:e152346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak J, Su Q, Yeoh Y, Lui G, Ng S, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. (2022) 71:544&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajeevan M, Murray J, Oakley L, Lin J, Unger E. Association of chronic fatigue syndrome with premature telomere attrition. J Transl Med. (2018) 16:44. 10.1186/s12967-018-1414-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1414-x</ArticleId><ArticleId IdType="pmc">PMC5830066</ArticleId><ArticleId IdType="pubmed">29486769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfera A, Osorio C, Zapata Martin Del Campo CM, Pereida S, Maurer S, Maldonado JC, et al. Endothelial senescence and chronic fatigue syndrome, a COVID-19 based hypothesis. Front Cell Neurosci. (2021) 15:673217. 10.3389/fncel.2021.673217</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.673217</ArticleId><ArticleId IdType="pmc">PMC8267916</ArticleId><ArticleId IdType="pubmed">34248502</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch S, Guo G, Gibson D, Bjourson A, Rai T. Role of senescence and aging in SARS-CoV-2 infection and COVID-19 Disease. Cells. (2021) 10:3367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8699414</ArticleId><ArticleId IdType="pubmed">34943875</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C, Pilling L, Atkins J, Masoli J, Delgado J, Tignanelli C, et al. Biological aging predicts vulnerability to COVID-19 severity in UK Biobank participants. J Gerontol A Biol Sci Med Sci. (2021) 76:e133&#x2013;41. 10.1093/gerona/glab060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glab060</ArticleId><ArticleId IdType="pmc">PMC7989601</ArticleId><ArticleId IdType="pubmed">33684206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T. Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis. (1994) 18(Suppl. 1):S62&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8148455</ArticleId></ArticleIdList></Reference><Reference><Citation>Majeed T, de Simone C, Famularo G, Marcellini S, Behan P. Abnormalities of carnitine metabolism in chronic fatigue syndrome. Eur J Neurol. (1995) 2:425&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24283722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuratsune H, Yamaguti K, Lindh G, Evengard B, Takahashi H, Machii T, et al. Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. Int J Mol Med. (1998) 2:51&#x2013;6. 10.3892/ijmm.2.1.51</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2.1.51</ArticleId><ArticleId IdType="pubmed">9854142</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M, Goodwin C, Amjad S, Chalmers R. Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome. Clin Chim Acta. (2005) 360:173&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15967423</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter S, Evans A. Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-l activity. J Intern Med. (2011) 270:76&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">21205027</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong C, McGregor N, Lewis D, Butt H, Gooley P. The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome. Metabolomics. (2017) 13:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux R, Naviaux J, Li K, Bright A, Alaynick W, Wang L, et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. (2016) 113:E5472&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine S, Hanson M. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol Biosyst. (2017) 13:371&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5365380</ArticleId><ArticleId IdType="pubmed">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Barupal D, Lee B, Che X, Williams B, Kahn E, et al. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Sci Rep. (2018) 8:10056. 10.1038/s41598-018-28477-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28477-9</ArticleId><ArticleId IdType="pmc">PMC6030047</ArticleId><ArticleId IdType="pubmed">29968805</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Barupal D, Levine S, Hanson M. Comprehensive circulatory metabolomics in ME/CFS reveals disrupted metabolism of acyl lipids and steroids. Metabolites. (2020) 10:34. 10.3390/metabo10010034</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10010034</ArticleId><ArticleId IdType="pmc">PMC7023305</ArticleId><ArticleId IdType="pubmed">31947545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoel F, Hoel A, Pettersen I, Rekeland I, Risa K, Alme K, et al. A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. (2021) 6:e149217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409979</ArticleId><ArticleId IdType="pubmed">34423789</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkiliza A, Parks M, Cseresznye A, Oberlin S, Evans J, Darcey T, et al. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms. J Transl Med. (2021) 19:370. 10.1186/s12967-021-03035-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03035-6</ArticleId><ArticleId IdType="pmc">PMC8401202</ArticleId><ArticleId IdType="pubmed">34454515</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass K, Germain A, Huang Y, Hanson M. Urine metabolomics exposes anomalous recovery after maximal exertion in female ME/CFS patients. Int J Mol Sci. (2023) 24:3685. 10.3390/ijms24043685</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043685</ArticleId><ArticleId IdType="pmc">PMC9958671</ArticleId><ArticleId IdType="pubmed">36835097</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E, Petrache I, Goldstein N, Olin J, Keith R, Modena B, et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am J Respir Crit Care Med. (2022) 205:126&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur V, Nemkov T, de Boer E, Mohning M, Baraghoshi D, Cendali F, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC). Metabolites. (2022) 12:1026. 10.3390/metabo12111026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Stromberg S, Baxter B, Dooley G, LaVergne S, Gallichotte E, Dutt T, et al. Relationships between plasma fatty acids in adults with mild, moderate, or severe COVID-19 and the development of post-acute sequelae. Front Nutr. (2022) 9:960409. 10.3389/fnut.2022.960409</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.960409</ArticleId><ArticleId IdType="pmc">PMC9515579</ArticleId><ArticleId IdType="pubmed">36185653</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Chang C, Yang C, Pariante C, Su K. Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav Immun. (2022) 103:19&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8977215</ArticleId><ArticleId IdType="pubmed">35390469</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M, Cooper E, Amjad S, Goodwin C, Barron J, Chalmers R. Urinary and plasma organic acids and amino acids in chronic fatigue syndrome. Clin Chim Acta. (2005) 361:150&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15992788</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong C, McGregor N, Sheedy J, Buttfield I, Butt H, Gooley PR. NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome. Clin Chim Acta. (2012) 413:1525&#x2013;31. 10.1016/j.cca.2012.06.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2012.06.022</ArticleId><ArticleId IdType="pubmed">22728138</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong C, McGregor N, Butt H, Gooley P. Metabolism in chronic fatigue syndrome. In: Makowski G. editor. Advances in Clinical Chemistry. Waltham, MA: Elsevier; (2014). p. 121&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">25344988</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong C, McGregor N, Lewis D, Butt H, Gooley P. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics. (2015) 11:1626&#x2013;39.</Citation></Reference><Reference><Citation>Fluge O, Mella O, Bruland O, Risa K, Dyrstad S, Alme K, et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. (2016) 1:e89376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5161229</ArticleId><ArticleId IdType="pubmed">28018972</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano E, Sugimoto M, Hirayama A, Kume S, Yamato M, Jin G, et al. Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci Rep. (2016) 6:34990. 10.1038/srep34990</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34990</ArticleId><ArticleId IdType="pmc">PMC5057083</ArticleId><ArticleId IdType="pubmed">27725700</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth T, Eaton-Fitch N, Staines D, Marshall-Gradisnik S. A systematic review of metabolomic dysregulation in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID). J Transl Med. (2020) 18:198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7222338</ArticleId><ArticleId IdType="pubmed">32404171</ArticleId></ArticleIdList></Reference><Reference><Citation>Groven N, Reitan S, Fors E, Guzey I. Kynurenine metabolites and ratios differ between chronic fatigue syndrome, fibromyalgia, and healthy controls. Psychoneuroendocrinology. (2021) 131:105287. 10.1016/j.psyneuen.2021.105287</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2021.105287</ArticleId><ArticleId IdType="pubmed">34090138</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonato M, Dall&#x2019;Acqua S, Zilli C, Sut S, Tenconi R, Gallo N, et al. Tryptophan metabolites, cytokines, and fatty acid binding protein 2 in myalgic encephalomyelitis/chronic fatigue syndrome. Biomedicines. (2021) 9:1724. 10.3390/biomedicines9111724</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111724</ArticleId><ArticleId IdType="pmc">PMC8615774</ArticleId><ArticleId IdType="pubmed">34829952</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, et al. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res. (2021) 20:3315&#x2013;29. 10.1021/acs.jproteome.1c00224</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataf S, Pays L. Molecular insights into SARS-CoV2-induced alterations of the gut/brain axis. Int J Mol Sci. (2021) 22:10440. 10.3390/ijms221910440</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910440</ArticleId><ArticleId IdType="pmc">PMC8508788</ArticleId><ArticleId IdType="pubmed">34638785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciregia F, Kollipara L, Giusti L, Zahedi R, Giacomelli C, Mazzoni M, et al. Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome. Transl Psychiatry. (2016) 6:e904. 10.1038/tp.2016.184</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2016.184</ArticleId><ArticleId IdType="pmc">PMC5048217</ArticleId><ArticleId IdType="pubmed">27676445</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine S, Hanson M. Prospective biomarkers from plasma metabolomics of myalgic encephalomyelitis/chronic fatigue syndrome implicate redox imbalance in disease symptomatology. Metabolites. (2018) 8:90. 10.3390/metabo8040090</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo8040090</ArticleId><ArticleId IdType="pmc">PMC6315598</ArticleId><ArticleId IdType="pubmed">30563204</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L, Conroy K, Furst J, Vasan K, Katz B. Pre-illness data reveals differences in multiple metabolites and metabolic pathways in those who do and do not recover from infectious mononucleosis. Mol Omics. (2022) 18:662&#x2013;5. 10.1039/d2mo00124a</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/d2mo00124a</ArticleId><ArticleId IdType="pmc">PMC10403250</ArticleId><ArticleId IdType="pubmed">35640165</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor N, Armstrong C, Lewis D, Gooley P. Post-exertional malaise is associated with hypermetabolism, hypoacetylation and purine metabolism deregulation in ME/CFS cases. Diagnostics (Basel). (2019) 9:E70. 10.3390/diagnostics9030070</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030070</ArticleId><ArticleId IdType="pmc">PMC6787670</ArticleId><ArticleId IdType="pubmed">31277442</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson N, Hsieh C, March D, Wang X. Elevated energy production in chronic fatigue syndrome patients. J Nat Sci. (2016) 2:e221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065105</ArticleId><ArticleId IdType="pubmed">27747291</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Brown A, Strassheim V, Elson J, Newton J, Manning P. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLos One. (2017) 12:e0186802. 10.1371/journal.pone.0186802</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186802</ArticleId><ArticleId IdType="pmc">PMC5655451</ArticleId><ArticleId IdType="pubmed">29065167</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Brown A, Newton J, Elson J. Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types. PeerJ. (2019) 7:e6500. 10.7717/peerj.6500</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.6500</ArticleId><ArticleId IdType="pmc">PMC6398432</ArticleId><ArticleId IdType="pubmed">30847260</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Elson J, Newton J, Walker M. Substrate utilisation of cultured skeletal muscle cells in patients with CFS. Sci Rep. (2020) 10:18232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588462</ArticleId><ArticleId IdType="pubmed">33106563</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Elson J, Strassheim V, Newton J, Walker M. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function. PLos One. (2020) 15:e0231136. 10.1371/journal.pone.0231136</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0231136</ArticleId><ArticleId IdType="pmc">PMC7147788</ArticleId><ArticleId IdType="pubmed">32275686</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Annesley S, Allan C, Sanislav O, Lidbury B, Lewis D, et al. An isolated Complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int J Mol Sci. (2020) 21:1074. 10.3390/ijms21031074</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031074</ArticleId><ArticleId IdType="pmc">PMC7036826</ArticleId><ArticleId IdType="pubmed">32041178</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Sanislav O, Allan C, Smith P, Annesley S, Fisher P. Dysregulated provision of oxidisable substrates to the mitochondria in ME/CFS lymphoblasts. Int J Mol Sci. (2021) 22:2046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7921983</ArticleId><ArticleId IdType="pubmed">33669532</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med Sci Monit. (2011) 17:SC11&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539515</ArticleId><ArticleId IdType="pubmed">21455120</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson M, Gray S, Watson M, Kennedy G, Hill A, Belch J, et al. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Scand J Med Sci Sports. (2010) 20:282&#x2013;90. 10.1111/j.1600-0838.2009.00895.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0838.2009.00895.x</ArticleId><ArticleId IdType="pubmed">19422646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G, Spence V, McLaren M, Hill A, Underwood C, Belch J. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med. (2005) 39:584&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16085177</ArticleId></ArticleIdList></Reference><Reference><Citation>Block T, Kuo J. Rationale for nicotinamide adenine dinucleotide (n.d.) metabolome disruption as a pathogenic mechanism of post-acute COVID-19 syndrome. Clin Pathol (2022) 15:2632010X221106986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9234841</ArticleId><ArticleId IdType="pubmed">35769168</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H, Al-Rubaye H, Al-Hadrawi D, Almulla A, Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol Psychiatry. (2023) 28:564&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients. (2021) 13:1154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R, Trimarco V, Mone P, Aloe T, Capra Marzani M, Diana A, et al. Combining L-arginine with vitamin C improves long-COVID symptoms: the LINCOLN Survey. Pharmacol Res. (2022) 183:106360. 10.1016/j.phrs.2022.106360</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="pubmed">35868478</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa K, Fujita M. Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome. Int J Cardiol. (2009) 136:238&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18684522</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y, Guillaume Steinberg J, Guieu R, Delliaux S. Chronic fatigue syndrome with history of severe infection combined altered blood oxidant status, and reduced potassium efflux and muscle excitability at exercise. Open J Int Med. (2013) 3:98&#x2013;105.</Citation></Reference><Reference><Citation>Fenouillet E, Vigouroux A, Steinberg J, Chagvardieff A, Retornaz F, Guieu R, et al. Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients. J Transl Med. (2016) 14:251. 10.1186/s12967-016-1010-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-016-1010-x</ArticleId><ArticleId IdType="pmc">PMC5006431</ArticleId><ArticleId IdType="pubmed">27580693</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Mihaylova I, Leunis J. Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neoepitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett. (2006) 27:615&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">17159817</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Berk M, Klein H, Walder K, Galecki P, Maes M. Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: new pathways in neuroprogressive disorders including depression and chronic fatigue syndrome. Mol Neurobiol. (2017) 54:4271&#x2013;91. 10.1007/s12035-016-9975-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9975-2</ArticleId><ArticleId IdType="pubmed">27339878</ArticleId></ArticleIdList></Reference><Reference><Citation>Monro J, Puri BK. A molecular neurobiological approach to understanding the aetiology of chronic fatigue syndrome (myalgic encephalomyelitis or systemic exertion intolerance disease) with treatment implications. Mol Neurobiol. (2018) 55:7377&#x2013;88. 10.1007/s12035-018-0928-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0928-9</ArticleId><ArticleId IdType="pmc">PMC6096969</ArticleId><ArticleId IdType="pubmed">29411266</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez A, Guillam&#xf3; E, Roig T, Bl&#xe1;zquez A, Alegre J, Berm&#xfa;dez J, et al. Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study. J Womens Health. (2010) 19:1073&#x2013;7. 10.1089/jwh.2008.1255</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2008.1255</ArticleId><ArticleId IdType="pubmed">20469961</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Maes M. Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). Curr Neuropharmacol. (2014) 12:168&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3964747</ArticleId><ArticleId IdType="pubmed">24669210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk G, Peterson D, Knox K, Maynard M, Whelan R, Roy A. Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE). Mol Cell Neurosci. (2022) 120:103731. 10.1016/j.mcn.2022.103731</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2022.103731</ArticleId><ArticleId IdType="pubmed">35487443</ArticleId></ArticleIdList></Reference><Reference><Citation>Shungu D, Weiduschat N, Murrough J, Mao X, Pillemer S, Dyke J, et al. Increased ventricular lactate in chronic fatigue syndrome. III. relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. (2012) 25:1073&#x2013;87. 10.1002/nbm.2772</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.2772</ArticleId><ArticleId IdType="pmc">PMC3896084</ArticleId><ArticleId IdType="pubmed">22281935</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B, Vu D, Coplan J, Mao X, Blate M, Kang G, et al. Elevations of ventricular lactate levels occur in both chronic fatigue syndrome and fibromyalgia. Fatigue. (2017) 5:15&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754037</ArticleId><ArticleId IdType="pubmed">29308330</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiades E, Behan W, Kilduff L, Hadjicharalambous M, Mackie E, Wilson J, et al. Chronic fatigue syndrome: new evidence for a central fatigue disorder. Clin Sci. (2003) 105:213&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12708966</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A, Morgan C, Llewelyn M, Albuquerque S, Farmer A. Heterogeneity of serum tryptophan concentration and availability to the brain in patients with chronic fatigue syndrome. J Psychopharm. (2005) 19:385&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">15982993</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz J, Nemkov T, Bertolone L, Francis R, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. (2020) 5:e140327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffieux H, Hanson A, Lodge S, Lawler N, Whiley L, Gray N, et al. A patient-centric modeling framework captures recovery from SARS-CoV-2 infection. Nat Immunol. (2023) 24:349&#x2013;58. 10.1038/s41590-022-01380-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01380-2</ArticleId><ArticleId IdType="pmc">PMC9892000</ArticleId><ArticleId IdType="pubmed">36717723</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A, Hepgul N, Nikkheslat N, Borsini A, Zajkowska Z, Moll N, et al. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology. (2019) 100:276&#x2013;85. 10.1016/j.psyneuen.2018.11.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2018.11.032</ArticleId><ArticleId IdType="pmc">PMC6350004</ArticleId><ArticleId IdType="pubmed">30567628</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Visser F. Comparing idiopathic chronic fatigue and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in males: response to two-day cardiopulmonary exercise testing protocol. Healthcare (Basel). (2021) 9:683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8230194</ArticleId><ArticleId IdType="pubmed">34198946</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Visser F. Female patients with myalgic encephalomyelitis/chronic fatigue syndrome or idiopathic chronic fatigue: comparison of responses to a two-day cardiopulmonary exercise testing protocol. Healthcare (Basel). (2021) 9:682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8229058</ArticleId><ArticleId IdType="pubmed">34198913</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin J, Atkinson G, Atkinson J, Batterham A. Peak oxygen uptake in chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis. Int J Sports Med. (2018) 40:77&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">30557887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E, Kang E, Jang E, Son C. The prospects of the two-day cardiopulmonary exercise test (CPET) in ME/CFS patients: a meta-analysis. J Clin Med. (2020) 9:4040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765094</ArticleId><ArticleId IdType="pubmed">33327624</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport T, Stevens S, Stevens J, Snell C, Van Ness J, Mooney A. Properties of measurements obtained during cardiopulmonary exercise testing in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Work. (2020) 66:247&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">32568145</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D, Nagelkirk P, Poluri A, Mores J, Natelson B. The influence of aerobic fitness and fibromyalgia on cardiorespiratory and perceptual responses to exercise in patients with chronic fatigue syndrome. Arthritis Rheum. (2006) 54:3351&#x2013;62. 10.1002/art.22124</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22124</ArticleId><ArticleId IdType="pubmed">17009309</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D, VanRiper S, Dougherty R, Lindheimer J, Falvo M, Chen Y, et al. Cardiopulmonary, metabolic, and perceptual responses during exercise in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study. PLos One. (2022) 17:e0265315. 10.1371/journal.pone.0265315</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0265315</ArticleId><ArticleId IdType="pmc">PMC8923458</ArticleId><ArticleId IdType="pubmed">35290404</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D, Brunjes D, Lala A, Trivieri M, Contreras J, Natelson B. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. (2021) 9:927&#x2013;37. 10.1016/j.jchf.2021.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavario P, De Marzo V, Lotti R, Barbara C, Porcile A, Russo C, et al. Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up. Int J Cardiol. (2021) 340:113&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302817</ArticleId><ArticleId IdType="pubmed">34311011</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonbank K, Lehmann A, Bernitzky D, Gysan M, Simon S, Schrott A, et al. Predictors of prolonged cardiopulmonary exercise impairment after COVID-19 infection: a prospective observational study. Front Med. (2021) 8:773788. 10.3389/fmed.2021.773788</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.773788</ArticleId><ArticleId IdType="pmc">PMC8740119</ArticleId><ArticleId IdType="pubmed">35004742</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannini L, Quijada-Fumero A, Martin M, Pina N, Afonso J. Cardiopulmonary exercise test with stress echocardiography in COVID-19 survivors at 6 months follow-up. Eur J Intern Med. (2021) 94:101&#x2013;4. 10.1016/j.ejim.2021.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.10.004</ArticleId><ArticleId IdType="pmc">PMC8502682</ArticleId><ArticleId IdType="pubmed">34654589</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y, Lichter Y, Sadon S, Lupu L, Taieb P, Banai A, et al. Cardiorespiratory abnormalities in patients recovering from coronavirus disease 2019. J Am Soc Echocardiogr. (2021) 34:1273&#x2013;84.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425293</ArticleId><ArticleId IdType="pubmed">34508837</ArticleId></ArticleIdList></Reference><Reference><Citation>Skjorten I, Ankerstjerne O, Trebinjac D, Bronstad E, Rasch-Halvorsen O, Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J. (2021) 58:2100996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247555</ArticleId><ArticleId IdType="pubmed">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo R, Mondoni M, Parazzini E, Baccelli A, Pitari F, Brambilla E, et al. Severity does not impact on exercise capacity in COVID-19 survivors. Respir Med. (2021) 187:106577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8364146</ArticleId><ArticleId IdType="pubmed">34416618</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo R, Mondoni M, Parazzini E, Pitari F, Brambilla E, Luraschi S, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. (2021) 58:2100870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J, Balagny P, Arnoult F, Mangin L, Bancal C, Vidal-Petiot E, et al. Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors. Eur Respir J. (2021) 58:2101578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8361302</ArticleId><ArticleId IdType="pubmed">34385265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr A, Dannerbeck L, Lange T, Pfeifer M, Blaas S, Salzberger B, et al. Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19. Multidisc Resp Med. (2021) 16:732. 10.4081/mrm.2021.732</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/mrm.2021.732</ArticleId><ArticleId IdType="pmc">PMC7893311</ArticleId><ArticleId IdType="pubmed">33623700</ArticleId></ArticleIdList></Reference><Reference><Citation>Debeaumont D, Boujibar F, Ferrand-Devouge E, Artaud-Macari E, Tamion F, Gravier F, et al. Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalization: a pilot study. Phys Ther. (2021) 101:1&#x2013;9. 10.1093/ptj/pzab099</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzab099</ArticleId><ArticleId IdType="pmc">PMC7989156</ArticleId><ArticleId IdType="pubmed">33735374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar M, Tunnicliffe E, Petousi N, Lewandowski A, Xie C, Mahmod M, et al. Symptom persistence despite improvement in cardiopulmonary health - Insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine. (2021) 41:101159. 10.1016/j.eclinm.2021.101159</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101159</ArticleId><ArticleId IdType="pmc">PMC8527025</ArticleId><ArticleId IdType="pubmed">34693230</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparisi A, Ladron R, Ybarra-Falcon C, Tobar J, San Roman J. Exercise intolerance in post-acute sequelae of COVID-19 and the value of cardiopulmonary exercise testing- a mini-review. Front Med. (2022) 9:924819. 10.3389/fmed.2022.924819</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.924819</ArticleId><ArticleId IdType="pmc">PMC9352932</ArticleId><ArticleId IdType="pubmed">35935782</ArticleId></ArticleIdList></Reference><Reference><Citation>Margalit I, Yelin D, Sagi M, Rahat M, Sheena L, Mizrahi N, et al. Risk factors and multidimensional assessment of long coronavirus disease fatigue: a nested case-control study. Clin Infect Dis. (2022) 75:1688&#x2013;97. 10.1093/cid/ciac283</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac283</ArticleId><ArticleId IdType="pmc">PMC9383780</ArticleId><ArticleId IdType="pubmed">35403679</ArticleId></ArticleIdList></Reference><Reference><Citation>Longobardi I, Prado D, Goessler K, Meletti M, de Oliveira Junior G, de Andrade D, et al. Oxygen uptake kinetics and chronotropic responses to exercise are impaired in survivors of severe COVID-19. Am J Physiol Heart Circ Physiol. (2022) 323:H569&#x2013;76. 10.1152/ajpheart.00291.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00291.2022</ArticleId><ArticleId IdType="pmc">PMC9448283</ArticleId><ArticleId IdType="pubmed">35984763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P, O&#x2019;Sullivan O, Bennett A, Barker-Davies R, Houston A, Chamley R, et al. The effect of medium-term recovery status after COVID-19 illness on cardiopulmonary exercise capacity in a physically active adult population. J Appl Physiol. (2022) 132:1525&#x2013;35. 10.1152/japplphysiol.00138.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00138.2022</ArticleId><ArticleId IdType="pmc">PMC9190734</ArticleId><ArticleId IdType="pubmed">35608204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P, O&#x2019;Sullivan O, Houston A, Barker-Davies R, May S, Mills D, et al. Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm. (2022) 19:613&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8656177</ArticleId><ArticleId IdType="pubmed">34896622</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt P, Cullinan M, Lutchmansingh D, Gulati M, et al. Persistent exertional intolerance after COVID-19. insights from invasive cardiopulmonary exercise testing. Chest. (2022) 161:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmig L, Rako Z, Ziegler S, Richter M, Ashkan Tolou GS, Roller F, et al. Long-term comprehensive cardiopulmonary phenotyping of COVID-19. Respir Res. (2022) 23:263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491263</ArticleId><ArticleId IdType="pubmed">36131349</ArticleId></ArticleIdList></Reference><Reference><Citation>Alba G, Ziehr D, Rouvina J, Hariri L, Knipe R, Medoff B, et al. Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea. EClinicalMedicine. (2021) 39:101066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401400</ArticleId><ArticleId IdType="pubmed">34476393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood G, Kirkevang T, Agergaard J, Leth S, Hansen E, Laustsen C, et al. Cardiac performance and cardiopulmonary fitness after infection with SARS-CoV-2. Front Cardiovasc Med. (2022) 9:871603. 10.3389/fcvm.2022.871603</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.871603</ArticleId><ArticleId IdType="pmc">PMC9136046</ArticleId><ArticleId IdType="pubmed">35647079</ArticleId></ArticleIdList></Reference><Reference><Citation>van Voorthuizen E, van Helvoort H, Peters J, van den Heuvel M, van den Borst B. Persistent exertional dyspnea and perceived exercise intolerance after mild COVID-19: a critical role for breathing dysregulation? Phys Ther. (2022) 102:zac105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384552</ArticleId><ArticleId IdType="pubmed">35900016</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J, Hoyo L, Wolf A, Hull E, Nunn S, Tadic M, et al. Cardiopulmonary exercise testing distinguishes between post-COVID-19 as a dysfunctional syndrome and organ pathologies. Int J Environ Res Public Health. (2022) 19:11421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9517475</ArticleId><ArticleId IdType="pubmed">36141693</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudry R, Brotto A, Varughese R, de Waal S, Fuhr D, Damant R, et al. Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls. Front Physiol. (2022) 13:917886. 10.3389/fphys.2022.917886</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.917886</ArticleId><ArticleId IdType="pmc">PMC9297912</ArticleId><ArticleId IdType="pubmed">35874528</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M, Sun K, Tahir P, Peluso M, Deeks S, Aras M, et al. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: a systematic review and meta-analysis. JAMA Netw Open. (2022) 5:e2236057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D, Hollingsworth K, Jakovljevic D, Fattakhova G, Pairman J, Blamire A, et al. Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study. Eur J Clin Invest. (2012) 42:186&#x2013;94. 10.1111/j.1365-2362.2011.02567.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2011.02567.x</ArticleId><ArticleId IdType="pubmed">21749371</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien K, Johansen B, Veierod M, Haslestad A, Bohn S, Melsom M, et al. Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome. Physiol Rep. (2019) 7:e14138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6546966</ArticleId><ArticleId IdType="pubmed">31161646</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Giloteaux L, Moore G, Levine S, Chia J, Keller B, et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. (2022) 7:e157621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9090259</ArticleId><ArticleId IdType="pubmed">35358096</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Booven D, Gamer J, Joseph A, Perez M, Zarnowski O, Pandya M, et al. Stress-induced transcriptomic changes in females with myalgic encephalomyelitis/chronic fatigue syndrome reveal disrupted immune signatures. Int J Mol Sci. (2023) 24:2698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9916639</ArticleId><ArticleId IdType="pubmed">36769022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilioni I, Natelson B, Theoharides T. Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis/chronic fatigue syndrome stimulates human microglia to release IL-1beta. Eur J Neurosci. (2022) 56:5784&#x2013;94. 10.1111/ejn.15828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15828</ArticleId><ArticleId IdType="pubmed">36153118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla S, Cook D, Meyer J, Vernon S, Le T, Clevidence D, et al. Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). PLos One. (2015) 10:e0145453. 10.1371/journal.pone.0145453</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0145453</ArticleId><ArticleId IdType="pmc">PMC4684203</ArticleId><ArticleId IdType="pubmed">26683192</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Pari R, Miller S, Warren A, Stovall M, Squires J, et al. Neurovascular dysregulation and acute exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, placebo-controlled trial of pyridostigmine. Chest. (2022) 162:1116&#x2013;26. 10.1016/j.chest.2022.04.146</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.04.146</ArticleId><ArticleId IdType="pubmed">35526605</ArticleId></ArticleIdList></Reference><Reference><Citation>Streeten D, Thomas D, Bell D. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci. (2000) 320:1&#x2013;8. 10.1097/00000441-200007000-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000441-200007000-00001</ArticleId><ArticleId IdType="pubmed">10910366</ArticleId></ArticleIdList></Reference><Reference><Citation>Farquhar W, Hunt B, Taylor J, Darling S, Freeman R. Blood volume and its relation to peak O2 consumption and physical activity in patients with chronic fatigue. Am J Physiol Heart Circ Physiol. (2002) 282:H66&#x2013;71. 10.1152/ajpheart.2002.282.1.H66</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2002.282.1.H66</ArticleId><ArticleId IdType="pubmed">11748048</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart J. Chronic fatigue syndrome: comments on deconditioning, blood volume and resulting cardiac function. Clin Sci. (2009) 118:121&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4236909</ArticleId><ArticleId IdType="pubmed">19534728</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurwitz B, Coryell V, Parker M, Martin P, Laperriere A, Klimas N, et al. Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clin Sci (Lond). (2010) 118:125&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">19469714</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton J, Finkelmeyer A, Petrides G, Frith J, Hodgson T, Maclachlan L, et al. Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study. Open Heart. (2016) 3:e000381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4932290</ArticleId><ArticleId IdType="pubmed">27403329</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Rowe P, Visser F. Blood volume status in ME/CFS correlates with the presence or absence of orthostatic symptoms: preliminary results. Front Pediatr. (2018) 6:352. 10.3389/fped.2018.00352</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00352</ArticleId><ArticleId IdType="pmc">PMC6262290</ArticleId><ArticleId IdType="pubmed">30525014</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore Y, Serafimova T, Anderson N, King H, Richards A, Brigden A, et al. Recovery from chronic fatigue syndrome: a systematic review-heterogeneity of definition limits study comparison. Arch Dis Child. (2021) 106:1087&#x2013;94. 10.1136/archdischild-2020-320196</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320196</ArticleId><ArticleId IdType="pmc">PMC8543221</ArticleId><ArticleId IdType="pubmed">33846138</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton D, Kennedy G, Chan K, Lang C, Belch J, Khan F. Large and small artery endothelial dysfunction in chronic fatigue syndrome. Int J Cardiol. (2012) 154:335&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22078396</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherbakov N, Szklarski M, Hartwig J, Sotzny F, Lorenz S, Meyer A, et al. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. ESC Heart Fail. (2020) 7:1064&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261521</ArticleId><ArticleId IdType="pubmed">32154656</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Tronstad KJ, Mella O. Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Clin Invest (2021) 131:e150377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8279575</ArticleId><ArticleId IdType="pubmed">34263741</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauensteiner J, Bertinat R, Le&#xf3;n L, Riederer M, Sep&#xfa;lveda N, Westermeier F. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients. Sci Rep. (2021) 11:10604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134566</ArticleId><ArticleId IdType="pubmed">34011981</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond J, Nielsen T, Hodges L. Effects of post-exertional malaise on markers of arterial stiffness in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Int J Environ Res Public Health. (2021) 18:2366. 10.3390/ijerph18052366</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052366</ArticleId><ArticleId IdType="pmc">PMC7957494</ArticleId><ArticleId IdType="pubmed">33671082</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rland K, Sandvik M, Rekeland I, Ribu L, Sm&#xe5;stuen M, Mella O, et al. Reduced endothelial function in myalgic encephalomyelitis/chronic fatigue syndrome&#x2013;results from open-label cyclophosphamide intervention study. Front Med. (2021) 8:642710. 10.3389/fmed.2021.642710</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.642710</ArticleId><ArticleId IdType="pmc">PMC8019750</ArticleId><ArticleId IdType="pubmed">33829023</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertinat R, Villalobos-Labra R, Hofmann L, Blauensteiner J, Sepulveda N, Westermeier F. Decreased NO production in endothelial cells exposed to plasma from ME/CFS patients. Vascul Pharmacol. (2022) 143:106953. 10.1016/j.vph.2022.106953</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106953</ArticleId><ArticleId IdType="pubmed">35074481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubell J. Letter: could endothelial dysfunction and vascular damage contribute to pain, inflammation and post-exertional malaise in individuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)? J Transl Med. (2022) 20:40. 10.1186/s12967-022-03244-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03244-7</ArticleId><ArticleId IdType="pmc">PMC8785571</ArticleId><ArticleId IdType="pubmed">35073915</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J, Kruger A, Proal A, Kell D, Pretorius E. The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Pharmaceuticals (Basel). (2022) 15:931. 10.3390/ph15080931</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15080931</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandvik M, Sorland K, Leirgul E, Rekeland I, Stavland C, Mella O, et al. Endothelial dysfunction in ME/CFS patients. PLos One. (2023) 18:e0280942. 10.1371/journal.pone.0280942</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0280942</ArticleId><ArticleId IdType="pmc">PMC9894436</ArticleId><ArticleId IdType="pubmed">36730360</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. (2020) 41:3038&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, Mayer M, Hellmers L, Ning B, Huang Z, Monjure C, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun. (2022) 13:1745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E, Souvaliotis N, Lampsas S, Siasos G, Poulakou G, Theofilis P, et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vascul Pharmacol. (2022) 144:106975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893931</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. (2021) 19:2546&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato G, et al. Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case-control study. Biomedicines. (2021) 9:957. 10.3390/biomedicines9080957</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080957</ArticleId><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro L, Falsetti L, Zaccone V, Nesci A, Tosato M, Giupponi B, et al. Impaired endothelial function in convalescent phase of COVID-19: a 3 month follow up observational prospective study. J Clin Med. (2022) 11:1774. 10.3390/jcm11071774</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071774</ArticleId><ArticleId IdType="pmc">PMC8999944</ArticleId><ArticleId IdType="pubmed">35407382</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M, Knauer M, Nicholson M, Daley M, Van Nynatten L, Martin C, et al. Elevated vascular transformation blood biomarkers in long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol Med. (2022) 28:122. 10.1186/s10020-022-00548-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaskamp L, Roubal C, Uddin S, Sotzny F, Kedor C, Bauer S, et al. Serum of post-COVID-19 syndrome patients with or without ME/CFS differentially affects endothelial cell function in vitro. Cells. (2022) 11:2376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9367589</ArticleId><ArticleId IdType="pubmed">35954219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, Vlok M, Turner S, Venter C, Laubscher G, Kell D, et al. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol. (2022) 21:190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltran-Camacho L, Eslava-Alcon S, Rojas-Torres M, Sanchez-Morillo D, Martinez-Nicolas M, Martin-Bermejo V, et al. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo. Mol Med. (2022) 28:40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994070</ArticleId><ArticleId IdType="pubmed">35397534</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Transl Med. (2022) 20:138. 10.1186/s12967-022-03346-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcic M, Marcic L, Lovric Kojundzic S, Marinovic Guic M, Marcic B, Caljkusic K. Chronic endothelial dysfunction after COVID-19 infection shown by transcranial color-coded Doppler: a cross-sectional study. Biomedicines. (2022) 10:2550. 10.3390/biomedicines10102550</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10102550</ArticleId><ArticleId IdType="pmc">PMC9599030</ArticleId><ArticleId IdType="pubmed">36289812</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, Calvani R, Picca A, Ciciarello F, Galluzzo V, Coelho-Junior H, et al. Effects of L-arginine plus vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: a single-blind randomized controlled trial. Nutrients. (2022) 14:4984. 10.3390/nu14234984</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14234984</ArticleId><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D, Laubscher G, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. (2022) 479:537&#x2013;59. 10.1042/BCJ20220016</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L, Kruger A, Venter C, Burger E, Laubscher G, Maponga T, et al. Relative hypercoagulopathy of the SARS-CoV-2 beta and delta variants when compared to the less severe omicron variants is related to TEG parameters, the extent of fibrin amyloid microclots, and the severity of clinical illness. Semin Thromb Hemost. (2022) 48:858&#x2013;68. 10.1055/s-0042-1756306</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1756306</ArticleId><ArticleId IdType="pubmed">36174604</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo A, Ba D, Parsons N, Poudel G, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. (2021) 4:e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respiratory Med. (2022) 10:863&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo J, Mart&#xed;nez-L&#xf3;pez J, Carrillo-Lamp&#xf3;n S, Ruiz-Ojeda D, Herrera-Ram&#xed;rez S, Amezcua-Guerra L, et al. Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort. Brain Sci. (2021) 11:760. 10.3390/brainsci11060760</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060760</ArticleId><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirfazeli F, Sarabi-Jamab A, Pereira-Sanchez V, Kordi A, Shariati B, Shariat S, et al. Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: a 9-month follow-up study. Neurol Sci. (2022) 43:2231&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776380</ArticleId><ArticleId IdType="pubmed">35059902</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Quach T, Tiwari A, Bonilla A, Miglis M, Yang P, et al. Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol. (2023) 14:1090747. 10.3389/fneur.2023.1090747</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessely S. History of postviral fatigue syndrome. Br Med Bull. (1991) 47: 919&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">1794091</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul O. DaCosta&#x2019;s syndrome or neurocirculatory asthenia. Br Heart J. (1987) 58:306&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1277260</ArticleId><ArticleId IdType="pubmed">3314950</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis. (1991) 13:S8&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">2020806</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelokov A, Habel K, Verder E, Welsh W. Epidemic neuromyasthenia: an outbreak of poliomyelitislike illness in student nurses. N Engl J Med. (1957) 257:345&#x2013;55. 10.1056/NEJM195708222570801</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM195708222570801</ArticleId><ArticleId IdType="pubmed">13464938</ArticleId></ArticleIdList></Reference><Reference><Citation>Poskanzer D, Henderson D, Kunkle E, Kalter S, Clement W, Bond J. Epidemic neuromyasthenia: an outbreak in Punta Gorda. Florida. N Engl J Med. (1957) 257: 356&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">13464939</ArticleId></ArticleIdList></Reference><Reference><Citation>Acheson ED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. Am J Med. (1959) 4:569&#x2013;95. 10.1016/0002-9343(59)90280-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(59)90280-3</ArticleId><ArticleId IdType="pubmed">13637100</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson D, Shelokov A. Epidemic neuromyasthenia &#x2013; clinical syndrome. N Engl J Med. (1959) 260:757&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">13644582</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine P, Jacobson S, Pocinki A, Cheney P, Peterson D, Connelly R, et al. Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med. (1992) 152:1611&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1323246</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical staff of the Royal Free Hospital. An outbreak of encephalomyelitis in the Royal Free Hospital Group, London, in l955. BMJ. (1957) 2:895&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1962472</ArticleId><ArticleId IdType="pubmed">13472002</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A, Fagioli L, Doolittle T, Gandek B, Gleit M, Guerriero R, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med. (1996) 101:281&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">8873490</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med. (1996) 171:364&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">8873506</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar M, Tunnicliffe E, Filippini N, Griffanti L, Alfaro-Almagro F, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. (2021) 31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons G, Glynn S, Komaroff A, Mikovits J, Tobler L, Hackett J, Jr., et al. Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science. (2011) 334:814&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3299483</ArticleId><ArticleId IdType="pubmed">21940862</ArticleId></ArticleIdList></Reference><Reference><Citation>Alter H, Mikovits J, Switzer W, Ruscetti F, Lo S, Klimas N, et al. A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus. mBio. (2012) 3:e266&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448165</ArticleId><ArticleId IdType="pubmed">22991430</ArticleId></ArticleIdList></Reference><Reference><Citation>Eveng&#xe5;rd B, Briese T, Lindh G, Lee S, Lipkin W. Absence of evidence of Borna disease virus infection in Swedish patients with chronic fatigue syndrome. J Neurovirol. (1999) 5:495&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10568886</ArticleId></ArticleIdList></Reference><Reference><Citation>Dansie E, Furberg H, Afari N, Buchwald D, Edwards K, Goldberg J, et al. Conditions comorbid with chronic fatigue in a population-based sample. Psychosomatics. (2012) 53:44&#x2013;50. 10.1016/j.psym.2011.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psym.2011.04.001</ArticleId><ArticleId IdType="pmc">PMC3254018</ArticleId><ArticleId IdType="pubmed">22221720</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested A, Bonilla H, Chheda B, Chu L, Curtin J, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. (2021) 96:2861&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H, Assaf G, McCorkell L, Wei H, Low R, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon S, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, et al. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. (2023) 74:1179&#x2013;86. 10.3233/WOR-220581</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220581</ArticleId><ArticleId IdType="pubmed">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Cuthbertson D, Wootton D, Crooks M, Gabbay M, Eichert N, et al. Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study. J R Soc Med. (2023) 116:97&#x2013;112. 10.1177/01410768231154703</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, O&#x2019;Boyle S, Palla L, Nacul F, Mudie K, Kingdon C, et al. How myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: the natural history of ME/CFS. Front Neurol. (2020) 11:826. 10.3389/fneur.2020.00826</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00826</ArticleId><ArticleId IdType="pmc">PMC7431524</ArticleId><ArticleId IdType="pubmed">32849252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R, Dini M, Rosci C, Capozza A, Groppo E, Reitano M, et al. One-year cognitive follow-up of COVID-19 hospitalized patients. Eur J Neurol. (2022) 29:2006&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111730</ArticleId><ArticleId IdType="pubmed">35285122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild C, Norton L, Menon D, Ripsman D, Swartz R, Owen A. Disentangling the cognitive, physical, and mental health sequelae of COVID-19. Cell Rep Med. (2022) 3:100750. 10.1016/j.xcrm.2022.100750</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100750</ArticleId><ArticleId IdType="pmc">PMC9448696</ArticleId><ArticleId IdType="pubmed">36103880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P, Benso F, Ferrazzoli D, Scarano I, Saltuari L, Sebastianelli L, et al. Global slowness and increased intra-individual variability are key features of attentional deficits and cognitive fluctuations in post COVID-19 patients. Sci Rep. (2022) 12:13123. 10.1038/s41598-022-17463-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-17463-x</ArticleId><ArticleId IdType="pmc">PMC9338963</ArticleId><ArticleId IdType="pubmed">35907947</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdsworth D, Chamley R, Barker-Davies R, O&#x2019;Sullivan O, Ladlow P, Mitchell J, et al. Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID. PLos One. (2022) 17:e0267392. 10.1371/journal.pone.0267392</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267392</ArticleId><ArticleId IdType="pmc">PMC9187094</ArticleId><ArticleId IdType="pubmed">35687603</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. (2022) 604:697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D, Bergquist J. Perspective: drawing on findings from critical illness to explain myalgic encephalomyelitis/chronic fatigue syndrome. Front Med. (2022) 9:818728. 10.3389/fmed.2022.818728</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.818728</ArticleId><ArticleId IdType="pmc">PMC8957276</ArticleId><ArticleId IdType="pubmed">35345768</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. (2020) 24:168&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. (2022) 28:911&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Preiser J, Ichai C, Orban J, Groeneveld A. Metabolic response to the stress of critical illness. Br J Anaesth. (2014) 113:945&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">24970271</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D, Larsson L, Bergquist J. Hypothesis: mechanisms that prevent recovery in prolonged ICU patients also underlie myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Front Med. (2021) 8:628029. 10.3389/fmed.2021.628029</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.628029</ArticleId><ArticleId IdType="pmc">PMC7876311</ArticleId><ArticleId IdType="pubmed">33585528</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D, Sepulveda N, Lim C, Bergquist J. Lessons from heat stroke for understanding myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. (2021) 12:789784. 10.3389/fneur.2021.789784</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.789784</ArticleId><ArticleId IdType="pmc">PMC8710546</ArticleId><ArticleId IdType="pubmed">34966354</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A, Lipkin W. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. (2021) 27:895&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B, Lemle M, Komaroff A, Snyder S. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci USA. (2021) 118:e2024358118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, Heijnen C, Kavelaars A, Laye S, Capuron L. The neuroimmune basis of fatigue. Trends Neurosci. (2014) 37:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3889707</ArticleId><ArticleId IdType="pubmed">24239063</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A, Haroon E, Felger J. The immunology of behavior-Exploring the role of the immune system in brain health and illness. Neuropsychopharmacology. (2017) 42:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5143516</ArticleId><ArticleId IdType="pubmed">27909328</ArticleId></ArticleIdList></Reference><Reference><Citation>Raizen D, Mullington J, Anaclet C, Clarke G, Critchley H, Dantzer R, et al. Beyond the symptom: the biology of fatigue. Sleep (2023) (in press).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10485572</ArticleId><ArticleId IdType="pubmed">37224457</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Cao Y, Zhang H, Wang Z, Man C, Yang Y, et al. COVID-19 metabolism: mechanisms and therapeutic targets. MedComm (2020). (2022) 3:e157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363584</ArticleId><ArticleId IdType="pubmed">35958432</ArticleId></ArticleIdList></Reference><Reference><Citation>Storey K, Storey J. Metabolic rate depression: the biochemistry of mammalian hibernation. Adv Clin Chem. (2010) 52:77&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">21275340</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessier S, Storey K. Transitioning between entry and exit from mammalian torpor: the involvement of signal transduction pathways. Temperature (Austin). (2014) 1:92&#x2013;3. 10.4161/temp.29972</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/temp.29972</ArticleId><ArticleId IdType="pmc">PMC4977171</ArticleId><ArticleId IdType="pubmed">27583287</ArticleId></ArticleIdList></Reference><Reference><Citation>Drew K, Buck C, Barnes B, Christian S, Rasley B, Harris M. Central nervous system regulation of mammalian hibernation: implications for metabolic suppression and ischemia tolerance. J Neurochem. (2007) 102:1713&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3600610</ArticleId><ArticleId IdType="pubmed">17555547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bargmann C, Horvitz H. Control of larval development by chemosensory neurons in Caenorhabditis elegans. Science. (1991) 251:1243&#x2013;6. 10.1126/science.2006412</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2006412</ArticleId><ArticleId IdType="pubmed">2006412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Hou X. Dauer in nematodes as a way to persist or obviate. Nematropica. (2015) 45:128&#x2013;37.</Citation></Reference><Reference><Citation>Penkov S, Kaptan D, Erkut C, Sarov M, Mende F, Kurzchalia T. Integration of carbohydrate metabolism and redox state controls dauer larva formation in Caenorhabditis elegans. Nat Commun. (2015) 6:8060. 10.1038/ncomms9060</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9060</ArticleId><ArticleId IdType="pubmed">26290173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>